<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN">
  <front>
    <journal-meta><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="publisher">pmed</journal-id><journal-id journal-id-type="nlm-ta">PLoS Med</journal-id><journal-id journal-id-type="pmc">plosmed</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Medicine</journal-title></journal-title-group><issn pub-type="ppub">1549-1277</issn><issn pub-type="epub">1549-1676</issn><publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher></journal-meta>
    <article-meta><article-id pub-id-type="doi">10.1371/journal.pmed.0030101</article-id><article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Neuroscience</subject>
          <subject>Biochemistry/Drug Discovery</subject>
          <subject>Obstetrics</subject>
          <subject>Pediatrics and Child Health</subject>
          <subject>Women's Health</subject>
        </subj-group>
        <subj-group subj-group-type="System Taxonomy">
          <subject>Neonates</subject>
          <subject>Obstetrics</subject>
          <subject>Pediatrics</subject>
          <subject>Pregnancy</subject>
          <subject>Substance use (including alcohol)</subject>
        </subj-group>
      </article-categories><title-group><article-title>Nicotinamide Protects against Ethanol-Induced Apoptotic Neurodegeneration in
          the Developing Mouse Brain</article-title><alt-title alt-title-type="running-head">Nicotinamide Inhibits Neuronal
          Apoptosis</alt-title></title-group><contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Ieraci</surname>
            <given-names>Alessandro</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Herrera</surname>
            <given-names>Daniel G</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
      </contrib-group><aff id="aff1">
        <label>1</label>
        <addr-line>Department of Psychiatry, Weill Medical College of Cornell University, New York,
          New York, United States of America </addr-line>
      </aff><contrib-group>
        <contrib contrib-type="editor" xlink:type="simple">
          <name name-style="western">
            <surname>Spong</surname>
            <given-names>Catherine Y.</given-names>
          </name>
          <role>Academic Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group><aff id="edit1">National Institute of Child Health and Human Development, United States of
        America</aff><author-notes>
        <corresp id="cor1">* To whom correspondence should be addressed. E-mail: <email xlink:type="simple">dah2007@med.cornell.edu</email>
        </corresp>
        <fn fn-type="con">
          <p> AI and DGH designed the study, analyzed the data, and contributed to writing the
            paper. AI performed the experiments. </p>
        </fn>
      <fn fn-type="conflict" id="n2">
        <p> The authors have declared that no competing interests exist. </p>
      </fn></author-notes><pub-date pub-type="ppub">
        <month>4</month>
        <year>2006</year>
      </pub-date><pub-date pub-type="epub">
        <day>21</day>
        <month>2</month>
        <year>2006</year>
      </pub-date><volume>3</volume><issue>4</issue><elocation-id>e101</elocation-id><history>
        <date date-type="received">
          <day>29</day>
          <month>7</month>
          <year>2005</year>
        </date>
        <date date-type="accepted">
          <day>30</day>
          <month>12</month>
          <year>2005</year>
        </date>
      </history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2006</copyright-year><copyright-holder>Ieraci and Herrera</copyright-holder><license><license-p>This is an open-access article distributed under the
        terms of the Creative Commons Attribution License, which permits unrestricted use,
        distribution, and reproduction in any medium, provided the original author and source are
        credited.</license-p></license></permissions><related-article page="e147" related-article-type="companion" vol="3" xlink:href="info:doi/10.1371/journal.pmed.0030147" xlink:title="synopsis" xlink:type="simple">
        <article-title>Nicotinamide: A Way to Prevent Fetal Alcohol Syndrome?</article-title>
      </related-article><related-article related-article-type="companion" xlink:href="info:doi/10.1371/journal.pmed.0030196" xlink:type="simple">
        <article-title>Protection against Prenatal Alcohol-Induced Damage</article-title>
      </related-article><abstract>
        <sec id="st1">
          <title>Background</title>
          <p>Exposure to alcohol during brain development may cause a neurological syndrome called
            fetal alcohol syndrome (FAS). Ethanol induces apoptotic neuronal death at specific
            developmental stages, particularly during the brain-growth spurt, which occurs from the
            beginning of third trimester of gestation and continues for several years after birth in
            humans, whilst occuring in the first two postnatal weeks in mice. Administration of a
            single dose of ethanol in 7-d postnatal (P7) mice triggers activation of caspase-3 and
            widespread apoptotic neuronal death in the forebrain, providing a possible explanation
            for the microencephaly observed in human FAS. The present study was aimed at determining
            whether nicotinamide may prevent ethanol-induced neurodegeneration.</p>
        </sec>
        <sec id="st2">
          <title>Methods and Findings</title>
          <p>P7 mice were treated with a single dose of ethanol (5g/kg), and nicotinamide was
            administered from 0 h to 8 h after ethanol exposure. The effects of nicotinamide on
            ethanol-induced activation of caspase-3 and release of cytochrome-c from the
            mitochondria were analyzed by Western blot ( <italic>n</italic> = 4–7/group).
            Density of Fluoro-Jade B–positive cells and NeuN-positive cells was determined
            in the cingulated cortex, CA1 region of the hippocampus, and lateral dorsal nucleus of
            the thalamus ( <italic>n</italic> = 5–6/group). Open field, plus maze, and
            fear conditioning tests were used to study the behavior in adult mice (
              <italic>n</italic> = 31–34/group). Nicotinamide reduced the activation of
            caspase-3 (85.14 ± 4.1%) and the release of cytochrome-c (80.78
            ± 4.39%) in postnatal mouse forebrain, too. Nicotinamide prevented
            also the ethanol-induced increase of apoptosis. We demonstrated that ethanol-exposed
            mice showed impaired performance in the fear conditioning test and increased activity in
            the open field and in the plus maze. Administration of nicotinamide prevented all these
            behavioral abnormalities in ethanol-exposed mice. </p>
        </sec>
        <sec id="st3">
          <title>Conclusions</title>
          <p>Our findings indicate that nicotinamide can prevent some of the deleterious effects of
            ethanol on the developing mouse brain when given shortly after ethanol exposure. These
            results suggest that nicotinamide, which has been used in humans for the treatment of
            diabetes and bullous pemphigoid, may hold promise as a preventive therapy of FAS.</p>
        </sec>
      </abstract><abstract abstract-type="toc">
        <p>Nicotinamide, a drug used routinely by human patients with a variety of conditions, is
          able to prevent some of the neurotoxic and behavioral effects of ethanol exposure in a
          mouse model of fetal alcohol syndrome.</p>
      </abstract><abstract abstract-type="patient">
        <title>Patient Summary</title>
        <sec id="sb1a">
          <title>Background</title>
          <p>When a woman drinks alcohol while she is pregnant, the alcohol goes to the baby through
            her bloodstream and can harm the baby. Some babies whose mothers had been drinking
            alcohol during pregnancy are born with fetal alcohol syndrome (FAS), a serious condition
            that can affect a child throughout life. Children with FAS have problems with
            development, learning, behavior, and social skills. In many Western countries, FAS is a
            common cause of mental retardation. Nicotinamide is a drug that has been used orally in
            patients with type-I diabetes and bullous pemphigoid (a chronic, autoimmune, blistering
            disease) and is generally well-tolerated.</p>
        </sec>
        <sec id="sb1b">
          <title>Why Was This Study Done?</title>
          <p>Nicotinamide has also been found to have neuroprotective properties (that means it can
            protect nerve cells). Because some of the problems associated with FAS are thought to be
            caused by the alcohol killing cells in the baby's brain, the researchers wanted to test
            whether nicotinamide could prevent some of the consequences of alcohol exposure. Before
            one can start testing such potential treatments in humans, it is necessary to do
            extensive studies in animal models (and only a small proportion of ideas that look
            promising in animal studies will eventually turn into useful treatments for human
            patients).</p>
        </sec>
        <sec id="sb1c">
          <title>What Did the Researchers Do and Find?</title>
          <p>They injected mouse pups shortly after birth with alcohol. Mouse brain development
            happens a bit later than in humans, and the time shortly after birth in mice corresponds
            to brain development in human babies during the third trimester of pregnancy. They found
            that this single exposure to alcohol (which is comparable with one-time excessive
            drinking in a pregnant mother) caused the death of brain cells in the mouse pups as well
            as a range of behavioral abnormalities after the pups had grown into adult mice. When
            they followed the injection of alcohol with a second injection of nicotinamide two hours
            later, the number of brain cells that died was no greater than during normal brain
            development, and the mice did not show behavioral abnormalities as adults.</p>
        </sec>
        <sec id="sb1d">
          <title>What Do These Findings Mean?</title>
          <p>This means that it might be possible, some years from now, to prevent some of the
            alcohol damage to the baby if the mother gets nicotinamide treatment soon after she was
            drinking alcohol. However, these are early-stage experiments done in a mouse model of
            FAS, and much more work is needed before it will become clear whether this or a similar
            treatment would work at all in humans. Moreover, FAS causes severe birth defects that
            are entirely preventable if a pregnant woman doesn't drink. Changing the behavior of
            pregnant women (and those who might become pregnant) therefore must be and will remain
            the focus of medical care.</p>
        </sec>
        <sec id="sb1e">
          <title>Where Can I Get More Information Online?</title>
          <p>The following Web sites have information on fetal alcohol syndrome.</p>
          <p>National Organization of Fetal Alcohol Syndrome:</p>
          <p>
            <ext-link ext-link-type="uri" xlink:href="http://www.nofas.org/about" xlink:type="simple">http://www.nofas.org/about</ext-link>
          </p>
          <p>The US Centers for Disease Control and Prevention (a list of relevant
            publications):</p>
          <p>
            <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/ncbddd/fas/faspub.htm" xlink:type="simple">http://www.cdc.gov/ncbddd/fas/faspub.htm</ext-link>
          </p>
          <p>Australian Health Insite:</p>
          <p>
            <ext-link ext-link-type="uri" xlink:href="http://www.healthinsite.gov.au/topics/Foetal_Alcohol_Syndrome" xlink:type="simple">http://www.healthinsite.gov.au/topics/Foetal_Alcohol_Syndrome</ext-link>
          </p>
          <p>Health on the Net Foundation:</p>
          <p>
            <ext-link ext-link-type="uri" xlink:href="http://www.hon.ch/Dossier/MotherChild/neonatal_problems/fetal_alcohol.html" xlink:type="simple">http://www.hon.ch/Dossier/MotherChild/neonatal_problems/fetal_alcohol.html</ext-link>
          </p>
          <p>US National Institute on Alcohol Abuse and Alcoholism:</p>
          <p>
            <ext-link ext-link-type="uri" xlink:href="http://www.niaaa.nih.gov/AboutNIAAA/Interagency/AboutFAS.htm" xlink:type="simple">http://www.niaaa.nih.gov/AboutNIAAA/Interagency/AboutFAS.htm</ext-link>
          </p>
        </sec>
      </abstract><funding-group><funding-statement> AI was supported by the Reader's Digest Fellowship, and DGH was supported by grants from
          the National Alliance for Research on Schizophrenia and Depression and the Reader's Digest
          Foundation. </funding-statement></funding-group></article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>Ethanol exposure during brain development can provoke neurodevelopmental defects referred
        to as fetal alcohol effects (FAE) or fetal alcohol syndrome (FAS), depending on their
        severity [<xref ref-type="bibr" rid="pmed-0030101-b001">1</xref>], with an
        array of neurological disorders including hyperactivity, learning and memory deficits,
        mental retardation, psychosis, depression, and schizophrenia [<xref ref-type="bibr" rid="pmed-0030101-b002">2</xref>, <xref ref-type="bibr" rid="pmed-0030101-b003">3</xref>]. A number of mechanisms have been proposed to contribute to ethanol
        neurotoxicity: oxidative stress, induction of apoptosis, excitotoxicity, disruption of
        cell–cell interaction, and interference with the activity of growth factors
          [<xref ref-type="bibr" rid="pmed-0030101-b004">4</xref>]. Several lines
        of evidence point out that consuming many drinks per occasion (i.e., binge drinking) is
        particularly harmful to the developing brain [<xref ref-type="bibr" rid="pmed-0030101-b005">5</xref>]. Ethanol may damage the developing brain by
        affecting neurogenesis, migration, or survival of cells [<xref ref-type="bibr" rid="pmed-0030101-b006">6</xref>, <xref ref-type="bibr" rid="pmed-0030101-b007">7</xref>]. Neurons are more susceptible to ethanol-induced apoptotic cell death
        during synaptogenesis, also known as the brain growth spurt [<xref ref-type="bibr" rid="pmed-0030101-b008">8</xref>, <xref ref-type="bibr" rid="pmed-0030101-b009">9</xref>], which in humans takes place during the third trimester of pregnancy,
        continuing for several years after birth [<xref ref-type="bibr" rid="pmed-0030101-b010">10</xref>]. Epidemiological studies indicate that FAS is
        the major non-genetic cause of mental retardation in the Western world [<xref ref-type="bibr" rid="pmed-0030101-b011">11</xref>]. Despite attempts to increase
        awareness of FAS, consumption of alcohol during pregnancy, especially binge drinking, has
        increased in recent years, and currently there are no effective treatments to prevent or
        revert FAS after ethanol exposure. </p>
      <p>Studies of alcohol exposure in developmental animal models are excellent tools to identify
        possible mechanisms and interventions that may prevent or attenuate ethanol's effect on the
        developing brain. A single heavy episode of ethanol exposure (binge-like drinking) in 7-d
        postnatal (P7) mice, a period of brain development that is comparable to the human third
        trimester, triggers widespread neurodegeneration, resulting in the loss of millions of
        neurons [<xref ref-type="bibr" rid="pmed-0030101-b012">12</xref>].
        Transplacental ethanol exposure in guinea pigs during synaptogenesis (a prenatal phenomenon
        in this species) promotes a similarly intense apoptotic response in the fetal brain
          [<xref ref-type="bibr" rid="pmed-0030101-b013">13</xref>].
        Neurodegeneration could provide a likely explanation for the reduced brain mass and
        neurobehavioral disturbances observed in human FAS. The cell death produced by ethanol in
        mice appears to be associated with activation of caspase-3, an executioner protease that is
        activated during apoptotic cell death [<xref ref-type="bibr" rid="pmed-0030101-b014">14</xref>, <xref ref-type="bibr" rid="pmed-0030101-b015">15</xref>]. </p>
      <p>Nicotinamide, an amide of vitamin B3, is the precursor for the coenzyme
        β-nicotinamide adenine dinucleotide (NAD+) and is considered to be necessary for
        cellular function and metabolism. Recently, interest in nicotinamide has shifted from its
        role as a nutrient to that as a novel neuroprotective agent [<xref ref-type="bibr" rid="pmed-0030101-b016">16</xref>]. Treatment with nicotinamide enhances neuronal
        survival during a variety of insults such as free radical exposure and oxidative stress
          [<xref ref-type="bibr" rid="pmed-0030101-b017">17</xref>, <xref ref-type="bibr" rid="pmed-0030101-b018">18</xref>], and in animals improves neurological outcome
        and reduces infarct volume in transient and permanent focal ischemia in vivo [<xref ref-type="bibr" rid="pmed-0030101-b019">19</xref>–<xref ref-type="bibr" rid="pmed-0030101-b021">21</xref>]. The mechanism of nicotinamide-mediated
        neuroprotection in vitro may be in part due to inhibition of caspase-3 and release of
        cytochrome-c from mitochondria during oxygen–glucose deprivation [<xref ref-type="bibr" rid="pmed-0030101-b022">22</xref>, <xref ref-type="bibr" rid="pmed-0030101-b023">23</xref>]. </p>
      <p>Based on these observations, we investigate whether nicotinamide is able to prevent the
        neurotoxic effects of ethanol exposure in the postnatal brain of mice. Furthermore, we
        analyze whether inhibition of ethanol-induced apoptotic neuronal death is sufficient to
        prevent behavioral impairment in adult mice.</p>
    </sec>
    <sec id="s2">
      <title>Methods</title>
      <sec id="s2a">
        <title>Animals</title>
        <p>P7 CD1 mice were injected subcutaneously with 20% ethanol in saline solution
          delivering 5g/kg body weight, and sacrificed at several time points. Nicotinamide and
          1-methyl-nicotinamide (Sigma, St. Louis, Missouri, United States) were dissolved in saline
          solution (50mg/ml) and were administered subcutaneously at different doses (0.25, 0.5, and
          1mg/g) and time points (0, 2, 4, or 8 h) after ethanol injection. Saline injections of
          equal volume were used as controls. In each litter, animals were equally distributed into
          the different treatment groups (see <xref ref-type="supplementary-material" rid="st001">Table S1</xref>). Animal care was provided according to the guidelines of Weill Medical
          College of Cornell University. </p>
      </sec>
      <sec id="s2b">
        <title>Western Blot Analysis</title>
        <p>Animals were killed at 2, 4, 8, 12, and 24 h after ethanol administration (see <xref ref-type="supplementary-material" rid="st001">Table S1</xref>). Brains were rapidly
          dissected out, and cerebellum, brain stem, and olfactory bulb were carefully removed and
          tissue was frozen in dry ice. For each treatment group, four to seven pups from 14
          different litters were analyzed. </p>
      </sec>
      <sec id="s2c">
        <title>Caspase-3 Western Blot</title>
        <p>Caspase-3 analysis was done as previously described with some modifications
            [<xref ref-type="bibr" rid="pmed-0030101-b015">15</xref>]. Forebrains
          were divided in half and lysed in boiling SDS buffer (250 mM tris-HCl [pH
          6.8], 2.5% SDS) followed by brief sonication and further centrifuged
          at 14,000 g for 20 min. Supernatant was collected and stored at −80 °C
          until further analysis. </p>
      </sec>
      <sec id="s2d">
        <title>Cytochrome-C Western Blot</title>
        <p>In order to analyze the release of cytochrome-c from the mitochondria into the cytoplasm,
          fresh tissue was prepared as previously described [<xref ref-type="bibr" rid="pmed-0030101-b024">24</xref>]. The forebrain was dissected in half, each
          sample cut into small pieces, and resuspended in ice cold buffer (250 mM sucrose, 20 mM
          HEPES, 10 mM KCl, 1.5 mM MgCl<sub>2</sub>, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM PMSF, 1 mM
          aprotinin, 1mM leupeptin) for 10 min. Tissue was homogenized by 30 strokes with a glass
          Dounce using a loose pestle. Intact cell and nuclei were centrifuged for 10 min at 750 g.
          The supernatant was further centrifuged at 14,000 g for 20 min, and the resultant
          supernatant was considered as cytosolic fraction and stored at −80 °C
          until further analysis. </p>
        <p>Material coming from different brains was never pooled. Protein concentration was
          determined with a DC Protein Assay Kit (Bio-Rad, Hercules, California, United States).
          Equal amounts of protein (50 μg) were boiled for 5 min in SDS loading buffer (50 mM
          Tris-Cl [pH 6.8], 2% SDS, 2%
          β-Mercaptoethanol, 0.1% bromophenol blue, 10% glycerol);
          resolved by 12%–15% SDS-PAGE gel, and transferred to PVDF
          membranes (Immobilon P, Millipore, Bedford, Massachusetts, United States) in a BioRad wet
          transfer unit. After transfer was completed, membranes were stained with Ponceau Red
          (Sigma) to verify loading, sample integrity, and protein separation. Membranes were
          blocked with 5% nonfat milk in TBS (10 mM Tris [pH 7.4]; 150
          mM NaCl, 0.1% Tween 20) for 1 h, and then incubated overnight at 4 °C
          with primary antibody. The following antibodies were used: anti-active caspase-3 antibody
          (1:1,000; Cell Signalling, Beverly, Massachusetts, United States), anti-cytochrome-c
          antibody (1:1,000; Pharmingen, San Diego, California, United States),
          anti-α-tubulin antibody (1:40,000; Sigma). Washed membranes were incubated with
          the appropriate horseradish peroxidase-conjugated secondary antibody (1:4000, Calbiochem,
          San Diego, California, United States) 1 h at room temperature, and immunoblotted proteins
          were detected by an enhanced chemiluminiscent method (Pierce, Rockford, Illinois, United
          States). For densitometric analysis, immunoreactive bands were scanned and intensity
          quantitated using NIH Image software (Scion, Frederick, Maryland, United States).</p>
      </sec>
      <sec id="s2e">
        <title>Ethanol Level Quantification</title>
        <p>Blood and brain samples were collected at 4, 8, 12, and 24 h after ethanol administration
          (see <xref ref-type="supplementary-material" rid="st001">Table S1</xref>). Mice from eight
          litters were sampled ( <italic>n</italic> = 4 for each treatment group for each time
          point). Blood was centrifuged at 3000 g for 20 min and plasma stored at −20
          °C until assayed. Brains were divided in half and lysed in 600 μl of cold
          EB buffer (1% Triton X-100, 10 mM Tris-HCL [pH7.5], 150mM
          NaCl, 5 mM EDTA, 10% Glycerol), centrifuged at 14,000 g for 20 min at 4
          °C, supernatant was collected and stored at −80 °C until
          assayed. Aliquots were taken to measure protein concentration. 10 μl of plasma and
          supernatant were used to determined ethanol level using the Ethanol Assay kit (DCL,
          Charlottetown, Prince Edward Island, Canada) in accordance with the manufacturer's
          recommendations. All samples were run in duplicate and averaged. </p>
      </sec>
      <sec id="s2f">
        <title>Morphological Analysis</title>
        <p>Animals were sacrificed 24 h (Fluoro-Jade B) or 14 d (NeuN [neuronal nuclear
          protein]) after ethanol treatment (see <xref ref-type="supplementary-material" rid="st001">Table S1</xref>). Five to six mice from a total of four different litters
          were analyzed for each treatment group. After intracardial perfusion with 4% of
          paraformaldehyde, brains were removed and post-fixed overnight at 4 °C. Brains
          were cut into 40-μm–thick transverse sections on a vibratome. </p>
      </sec>
      <sec id="s2g">
        <title>Fluoro-Jade–B Staining</title>
        <p>Fluoro-Jade–B staining was performed as previously described [<xref ref-type="bibr" rid="pmed-0030101-b025">25</xref>]. Briefly, sections were
          mounted on slides and then air dried over night. The slides were immersed in a solution of
          1% sodium hydroxide and 80% ethanol for 5 min, then in
          70% alcohol for 2 min followed by 2 min in distilled water. Slides were
          transferred in 0.06% potassium permanganate solution for 10 min. After rinsed
          in water, slides were immersed in a solution of 0.1% acetic acid and
          0.0004% Fluoro-Jade B (Calbiochem, San Diego, California, United States) for 20
          min. Slides were washed 3× in distillated water, allowed to dry at 55 °C
          for 10 min, and mounted with Krystalon (EMD Chemicals, Gibbstown, New Jersey, United
          States). </p>
      </sec>
      <sec id="s2h">
        <title>NeuN Immunohistochemistry</title>
        <p>For NeuN immunohistochemistry, floating sections were incubated for 20 min in
          3% H<sub>2</sub>O<sub>2</sub>. After rinsing in PBS, sections were incubated 30
          min in blocking solution (PBS, 10% goat serum, 0.3% Triton-X100).
          Sections were then incubated with an anti-NeuN antibody (1:500; Chemicon, Temecular,
          California, United States) overnight at 4 °C. Sections were rinsed and incubated 1
          h at room temperature with biotinylated anti-mouse (1:200; Chemicon), followed by the
          peroxidase-based Vectstain ABC system (Vector Labs, Burlingame, California, United States)
          using diaminobenzidine (Sigma) as the chromogen. Staining with NeuN is markedly superior
          to that produced by the Nissl method: neurons are stained with a greater intensity and
          with more defined contours (personal observation and [<xref ref-type="bibr" rid="pmed-0030101-b026">26</xref>]). Counting of neuronal populations with NeuN
          immunostaining is not only comparable to that done with Nissl but may also reduce errors
          when counting small neurons [<xref ref-type="bibr" rid="pmed-0030101-b026">26</xref>]. </p>
      </sec>
      <sec id="s2i">
        <title>Cell Counting</title>
        <p>Cells were counted one section out of every six (240 μm apart from each other)
          throughout the brain by using a Nikon Eclipse E600 with a Nikon 40× objective.
          Two to four sections per brain for the LDN (lateral dorsal nucleus) of thalamus, and six
          to ten sections per brain for the CA1 and the cingulate cortex were counted in five to six
          animals of each group. Cells were counted in both hemispheres. Contours of Cingulate CX
          (Bregma from 1.34 to −0.82), CA1 (dorsal part Bregma from −1.22 to
          −1.84; ventral part Bregma from −3.52 to −.88) and LDN
          (Bregma from −1.06 to −1.46) [<xref ref-type="bibr" rid="pmed-0030101-b027">27</xref>] were traced using a personal computer, and
          the area was calculated with Stereo Investigator software (MBF Bioscience, Williston,
          Vermont, United States). The section thickness was measured at different random locations,
          and the range was: 8–12 μm for Fluoro-Jade B and 18–22
          μm for NeuN stain. The relative area densities (counts/mm<sup>2</sup>) of
          Fluoro-Jade B–positive cell profiles were estimated using the fractionator probe
          and systematic random sampling (MBF Bioscience), and counting was done between
          2–5 d after staining the sections for Fluoro-Jade B. There was no significant
          fading of fluorescence when randomly selected sections were recounted blindly 10 d later,
          agreeing with previously published data [<xref ref-type="bibr" rid="pmed-0030101-b025">25</xref>]. Pilot studies revealed no consistent
          differences in profile size between control and treated animals. The density of NeuN+
          cells (counts/mm<sup>3</sup>) was estimated with the optical dissector method, which has
          been described previously [<xref ref-type="bibr" rid="pmed-0030101-b028">28</xref>–<xref ref-type="bibr" rid="pmed-0030101-b030">30</xref>].
          The results were normalized and expressed as percentage of control. Briefly, the number of
          neurons (Q) was counted in a dissector volume (V<sub>dis</sub>) defined by the product of
          a counting frame and the distance between two dissectors planes ( <italic>h</italic>). The
          density of cells (N<sub>v</sub>) was determined by dividing the total number of counting
          cells (Q) by the total volume in which cells were counted (V<sub>dis</sub>). Twenty-five
          to 30 different fields were randomly selected for each region in each section analyzed and
          a total of 200–400 cells/region/brain were counted with a CE of
          0.07–0.05. The dimension of the counting frame was 50 × 50 μm
          with a dissector depth <italic>(h)</italic> of 12 μm for the cingulate cortex and
          the LDN of thalamus, while for the CA1 region it was 20 × 20 μm with a
          dissector depth of 8 μm. A 2-μm guard space from the top was used. Counting
          was conducted in a blinded manner. </p>
      </sec>
      <sec id="s2j">
        <title>Behavioral Tests</title>
        <p>P7 mice received subcutaneous injection of saline or ethanol, and nicotinamide was
          administrated 2 h later. The different treatments were distributed across sexes and
          litters as evenly as possible. Animals remained with the lactating dam until P21, at which
          time they were separated by sex and housed under a 12:12 h light/dark cycle in a
          temperature- and humidity-controlled animal facility. Behavioral tests were started on P60
          and the total time necessary to run all tests was 5–6 wk. Thirty-one to 34
          animals (from a total of 16 different litters) were sampled for each treatment group (see
            <xref ref-type="supplementary-material" rid="st001">Table S1</xref>). All the
          experiments were conducted in a blind manner. Animals were separated by treatment and four
          to five animals were housed per cage. A person who did not know how the mice have been
          treated coded each cage. At the end of the entire behavioral test, the codes were opened.
          Mice were tested in open field, plus maze, and fear conditioning tests, tests widely used
          to study behavioral changes in animal expose to ethanol in the perinatal period
            [<xref ref-type="bibr" rid="pmed-0030101-b031">31</xref>–<xref ref-type="bibr" rid="pmed-0030101-b034">34</xref>]. </p>
      </sec>
      <sec id="s2k">
        <title>Open Field</title>
        <p>The open field test was performed as described previously [<xref ref-type="bibr" rid="pmed-0030101-b033">33</xref>, <xref ref-type="bibr" rid="pmed-0030101-b035">35</xref>]. Mice were placed in a 50 × 50 cm square chamber for 5
          min. The floor was divided into nine squares. The test was conducted in the dark. Each
          mouse was place in the center of the box. Each session was videotaped. Horizontal (lines
          crossed) and vertical (rearing) activities were recorded. </p>
      </sec>
      <sec id="s2l">
        <title>Elevated Plus Maze</title>
        <p>Elevated plus maze was performed as described previously [<xref ref-type="bibr" rid="pmed-0030101-b033">33</xref>, <xref ref-type="bibr" rid="pmed-0030101-b036">36</xref>]. The apparatus consisted of two open arms (30 × 5 cm),
          two closed arms (30 × 5 cm with 15 cm high black wall), and a connecting central
          platform (5 × 5 cm). Each mouse was placed in the center facing one open arm and
          then allowed to explore the maze for 5 min. The test was conducted in the dark light.
          Animals were videotaped and scored for total entries into all arms, percent of total
          entries into the open arm, and percent of total time spent in the open arms. </p>
      </sec>
      <sec id="s2m">
        <title>Fear Conditioning</title>
        <p>The fear conditioning test was performed as described previously [<xref ref-type="bibr" rid="pmed-0030101-b031">31</xref>, <xref ref-type="bibr" rid="pmed-0030101-b037">37</xref>]. On day 1 of training, mice were placed
          individually in the conditioning chamber (chamber A) (Coulbourn Instruments, Allentown,
          Pennsylvania, United States). After 2 min of habituation, three tone-shock pairs were
          given at 1-min intervals. Each tone-shock pair consisted of a 20-s acoustic white noise
          tone (CS) (70db, 2.9KHz), followed by a 1-s foot shock (US). One minute after the third
          shock, mice were returned to their home cage. On day 2, mice were placed in the same
          environment (contextual conditioning), and the total freezing (cessation of all movement
          other than respiration) time was measured for 5 min. On day 3, mice were placed in a
          different chamber (chamber B) and after 120 s three separate CS of 20 s were delivered at
          1 min intervals (cued conditioning). Freezing was scored and expressed as the percentage
          of time spent freezing. To exclude the possibility that differences in the time freezing
          were due to an altered activity, the basal level of freezing in the animals was scored for
          2 min the first day before the training (pre-testing) and the third day before the
          presentation of the tone (pre-tone). Some of the animals were not scored in the
          pre-training and in the pre-tone analysis because the videotape was not available. </p>
      </sec>
      <sec id="s2n">
        <title>Data Analysis</title>
        <p>Statistical analyses were performed with STAT VIEW software (SAS Institute, Cary, North
          Carolina, United States). Data are presented as mean ± standard deviation (SD).
          Statistical analyses were made using analysis of variance (ANOVA), and Bonferroni's
          procedure was used for multiple comparison analysis.</p>
      </sec>
    </sec>
    <sec id="s3">
      <title>Results</title>
      <sec id="s3a">
        <title>Nicotinamide Inhibits Ethanol-Induced Apoptotic Pathway</title>
        <p>P7 mice were injected subcutaneously with a 20% solution of ethanol in normal
          saline delivering 5 g/kg, and sacrificed at different time points. This dose maintained a
          blood ethanol concentration above 200 mg/dl for several hours, which is the minimum level
          needed for triggering neurodegeneration consistently [<xref ref-type="bibr" rid="pmed-0030101-b012">12</xref>, <xref ref-type="bibr" rid="pmed-0030101-b014">14</xref>]. This blood ethanol level is in the range that a human fetus might
          be exposed to after maternal ingestion of a moderate to heavy dose of ethanol
            [<xref ref-type="bibr" rid="pmed-0030101-b038">38</xref>]. A clear
          activation of caspase-3 was observed 4 h after ethanol administration; it peaked at 12 h
          and was still evident 24 h after ethanol treatment ( <xref ref-type="supplementary-material" rid="sg001">Figure S1</xref>A). </p>
        <p>In order to determine if nicotinamide can inhibit ethanol-induced caspase-3 activation, a
          series of different experiments was performed (<xref ref-type="fig" rid="pmed-0030101-g001">Figure 1</xref>). In a first set of experiments, increasing
          doses of nicotinamide were administered subcutaneously 2 h after ethanol exposure. 12 h
          after treatment, animals injected with ethanol alone showed a 15-fold to 20-fold increase
          of cleaved caspase-3 compared with a saline control (<xref ref-type="fig" rid="pmed-0030101-g001">Figure 1</xref>A and <xref ref-type="fig" rid="pmed-0030101-g001">1</xref>C; <xref ref-type="supplementary-material" rid="st002">Table S2</xref>). Administration of nicotinamide reduced caspase-3 activation, and
          maximum inhibition was seen with a 1 mg/g dose (<xref ref-type="fig" rid="pmed-0030101-g001">Figure 1</xref>A and <xref ref-type="fig" rid="pmed-0030101-g001">1</xref>C; <xref ref-type="supplementary-material" rid="st002">Table S2</xref>). To rule out the possibility that nicotinamide might only delay
          caspase-3 activation, we evaluated the effects of nicotinamide on caspase-3 activation 24
          h after ethanol administration. Cleaved caspase-3 was increased 3-fold–4-fold in
          ethanol-treated mice compared with controls (<xref ref-type="fig" rid="pmed-0030101-g001">Figure 1</xref>B and <xref ref-type="fig" rid="pmed-0030101-g001">1</xref>D; <xref ref-type="supplementary-material" rid="st003">Table S3</xref>). However, one single
          injection of nicotinamide 2 h after ethanol administration was sufficient to reduce
          ethanol-induced caspase-3 activation by approximately 50% after 24 h (<xref ref-type="fig" rid="pmed-0030101-g001">Figure 1</xref>B and <xref ref-type="fig" rid="pmed-0030101-g001">1</xref>D; <xref ref-type="supplementary-material" rid="st003">Table S3</xref>). </p>
        <fig id="pmed-0030101-g001" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pmed.0030101.g001</object-id>
          <label>Figure 1</label>
          <caption>
            <title>Nicotinamide Inhibits Ethanol-Induced Caspase-3 Activation</title>
            <p>(A–D) P7 mice were injected with ethanol and received nicotinamide 2 h
              later.</p>
            <p>(A and B) Level of cleaved caspase-3 was analyzed by Western blot at 12 h (A) and 24
              h (B) after ethanol administration with different doses of nicotinamide.</p>
            <p>(C and D) Densitometric quantification of cleaved caspase-3 at 12 h (ANOVA
                  <italic>F<sub>5,27</sub>
              </italic> = 10.989; <italic>p</italic> &lt; 0.0001; <italic>n</italic> =
              5–6 each treatment group) (C) and 24 h (ANOVA <italic>F<sub>3,18</sub>
              </italic> = 8.851; <italic>p</italic> = 0.0008; <italic>n</italic> = 6 each treatment
              group) (D). </p>
            <p>(E and G) Nicotinamide was administered to P7 mice at different time points after
              ethanol exposure. Western blot analysis of caspase-3 activation 12 h after ethanol
              injection (E) and densitometric quantification (ANOVA <italic>F<sub>5,33</sub>
              </italic> = 15.061; <italic>p &lt;</italic> 0.0001; <italic>n</italic> =
              6–7 each treatment group) (G). </p>
            <p>(F and H) Different doses of ethanol were administered to P7 mice and nicotinamide
              was injected 2 h later. Western blot analysis of caspase-3 activation 12 h after
              ethanol injection (F) and densitometric quantification (ANOVA <italic>F<sub>6,28</sub>
              </italic> = 18.183; <italic>p &lt;</italic> 0.0001; <italic>n</italic> = 5 each
              treatment group) (H). Values are shown as mean ± SD. Bonferroni correction
              for multiple comparisons revealed a significant difference between the ethanol
              treatment group and all other groups. ∗ <italic>p &lt;</italic> 0.0001.
            </p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.0030101.g001" xlink:type="simple"/>
        </fig>
        <p>In a second set of experiments, animals received nicotinamide (1 mg/g) at 0, 2, 4, or 8 h
          after ethanol administration. Activation of caspase-3 was assessed 12 h after ethanol
          exposure. We found that nicotinamide treatment prevented ethanol-induced activation of
          caspase-3 at all time points tested, and the strongest effect was observed when
          nicotinamide was administered between 0 h and 2 h after ethanol exposure (<xref ref-type="fig" rid="pmed-0030101-g001">Figure 1</xref>E and <xref ref-type="fig" rid="pmed-0030101-g001">1</xref>G; <xref ref-type="supplementary-material" rid="st004">Table S4</xref>). </p>
        <p>To verify that nicotinamide was also able to prevent the ethanol-induced activation of
          caspase-3 at a lower ethanol concentration, mice were exposed to 2.5, 4, or 5g/kg of
          ethanol, and nicotinamide was injected 2 h later. A dose of 2.5 g/kg was not enough to
          consistently detect caspase-3 activation 12 h after ethanol treatment in the whole
          forebrain (<xref ref-type="fig" rid="pmed-0030101-g001">Figure 1</xref>F and <xref ref-type="fig" rid="pmed-0030101-g001">1</xref>H). Nicotinamide administration prevented
          ethanol-induced activation of caspase-3 at 4 or 5g/kg of ethanol exposure (<xref ref-type="fig" rid="pmed-0030101-g001">Figure 1</xref>F and <xref ref-type="fig" rid="pmed-0030101-g001">1</xref>H; <xref ref-type="supplementary-material" rid="st005">Table S5</xref>). </p>
        <p>Finally, to test the specificity of actions of nicotinamide, we administrated
          1-methyl-nicotinamide, an analogue of nicotinamide, 2 h after ethanol exposure. This
          analogue is not converted into NAD+, and its administration did not prevent
          ethanol-induced caspase-3 activation (Figure S2B and S2C; <xref ref-type="supplementary-material" rid="st006">Table S6</xref>). </p>
        <p>Based on these findings, ethanol was administered at 5 g/kg and nicotinamide at 1 mg/g, 2
          h after ethanol treatment in the rest of the experiments.</p>
        <p>Release of cytochrome-c into the cytoplasm induces the formation of apoptosome, which in
          turn activates caspase-3 [<xref ref-type="bibr" rid="pmed-0030101-b014">14</xref>, <xref ref-type="bibr" rid="pmed-0030101-b023">23</xref>]. Recently,
          it has been shown that ethanol-induced neuronal death is Bax-dependent and involves the
          release of cytochrome-c from the mitochondria [<xref ref-type="bibr" rid="pmed-0030101-b039">39</xref>]. Since nicotinamide can block the
          cytochrome-c release in vitro, we tested whether inhibition of cytochrome-c release might
          be the target of nicotinamide in vivo (<xref ref-type="fig" rid="pmed-0030101-g002">Figure
            2</xref>). <xref ref-type="fig" rid="pmed-0030101-g002">Figure 2</xref>A and <xref ref-type="fig" rid="pmed-0030101-g002">2</xref>C shows that in ethanol-treated pups
          there is a 20-fold increase of cytochrome-c release after 12 h compared with controls, and
          that administration of nicotinamide significantly reduced this release (<xref ref-type="fig" rid="pmed-0030101-g002">Figure 2</xref>A and <xref ref-type="fig" rid="pmed-0030101-g002">2</xref>C; <xref ref-type="supplementary-material" rid="st007">Table S7</xref>). </p>
        <fig id="pmed-0030101-g002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pmed.0030101.g002</object-id>
          <label>Figure 2</label>
          <caption>
            <title>Nicotinamide Blocks Release of Cytochrome-C from Mitochondria</title>
            <p>(A) Western blot analysis of cytochrome-c release in the cytosolic fraction 12 h
              after ethanol administration.</p>
            <p>(C) Densitometric quantification of cytochrome-c release (ANOVA
                  <italic>F<sub>3,20</sub>
              </italic> = 43.546 <italic>p &lt;</italic> 0.0001; <italic>n</italic> = 6 each
              treatment group). Values are shown as mean ± SD. Bonferroni correction for
              multiple comparison revealed a significant difference between ethanol treatment group
              and all other groups. ∗ <italic>p &lt;</italic> 0.0001. </p>
            <p>(B and D) Nicotinamide (1mg/g) does not alter ethanol absorption or excretion.
              Ethanol levels in blood (B) and brain (D) were measured at different time points after
              5g/kg of ethanol treatment in P7 mice. Nicotinamide was administered 2 h after ethanol
              exposure. No significant differences were seen between the different treatments (
                <italic>n</italic> = 4 each treatment group). </p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.0030101.g002" xlink:type="simple"/>
        </fig>
      </sec>
      <sec id="s3b">
        <title>Nicotinamide Does Not Alter the Metabolism of Ethanol</title>
        <p>Metabolism of ethanol through alcohol dehydrogenase requires NAD+ with production of
          acetaldehyde. Further oxidation of acetaldehyde is mediated predominantly by the
          mitochondrial aldehyde dehydrogenase, which also needs NAD+. Therefore, the rate-limiting
          factor in the metabolism of ethanol is the amount of NAD+. It has been shown that
          administration of nicotinamide increases the level of NAD+ [<xref ref-type="bibr" rid="pmed-0030101-b017">17</xref>]. To test if nicotinamide could modify the
          metabolism of ethanol, we measured alcohol level in the blood and in the brain at several
          time points after ethanol administration, with and without nicotinamide. <xref ref-type="fig" rid="pmed-0030101-g002">Figure 2</xref>B and <xref ref-type="fig" rid="pmed-0030101-g002">2</xref>D shows that 1mg/g of nicotinamide did not change the
          pharmacokinetics of ethanol (as alcohol levels neither in the blood nor in the brain were
          affected) (<xref ref-type="fig" rid="pmed-0030101-g002">Figure 2</xref>B and <xref ref-type="fig" rid="pmed-0030101-g002">2</xref>D). </p>
      </sec>
      <sec id="s3c">
        <title>Nicotinamide Inhibits Ethanol-Induced Neuronal Death</title>
        <p>Following activation, caspase-3 is responsible for the cleavage of a broad spectrum of
          cellular targets, ultimately leading to cell death. In addition, other caspase-3
          independent mechanisms may also be involved in apoptotic cell death. To determine whether
          inhibition of caspase-3 activation by nicotinamide is sufficient to prevent
          ethanol-induced cell death, brains were histologically analyzed for evidence of
          neurodegeneration. 24 h after ethanol treatment, Fluoro-Jade–B staining,
          predominantly a marker of neuronal injury [<xref ref-type="bibr" rid="pmed-0030101-b025">25</xref>], revealed neurodegeneration throughout the
          forebrain of ethanol-treated mice. In contrast, mice that received nicotinamide after
          ethanol administration showed a dramatic reduction in Fluoro-Jade–B labeling
            (<xref ref-type="fig" rid="pmed-0030101-g003">Figure 3</xref>A). Quantification of
          Fluoro-Jade–B positive cells in regions particularly sensitive to ethanol at
          this developmental stage (anterior cingulate cortex, CA1 of the hippocampus, and LDN of
          thalamus), confirmed that administration of nicotinamide reduced the number of neurons
          injured by ethanol exposure (<xref ref-type="fig" rid="pmed-0030101-g003">Figure
          3</xref>B). Furthermore, using NeuN, a marker of mature neurons [<xref ref-type="bibr" rid="pmed-0030101-b026">26</xref>], we established that there
          was a significant decrease in the number of mature neurons in the anterior cingulate
          cortex (488,792 ± 11,828 versus 450,392 ± 5,548; <italic>p</italic>
          = 0.01) and in the LDN of the thalamus (255,588 ± 11,583 versus 206,022
          ± 13,017; <italic>p</italic> = 0.004) 14 d after ethanol exposure. In the
          hippocampus, while there was only a trend in the dorsal CA1 region (641,056 ±
          38,388 versus 570,796 ± 26,311; <italic>p</italic> = 0.08), a significant
          statistical difference was present in the ventral region (707,552 ± 47,241
          versus 556,756 ± 21,322; <italic>p</italic> = 0.02). Nicotinamide treatment
          prevented the ethanol-induced decrease of the number of neurons in all of these regions
            (<xref ref-type="fig" rid="pmed-0030101-g003">Figure 3</xref>C). </p>
        <fig id="pmed-0030101-g003" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pmed.0030101.g003</object-id>
          <label>Figure 3</label>
          <caption>
            <title>Nicotinamide Inhibits Ethanol-Induced Neurodegeneration</title>
            <p>(A) Fluoro-Jade B staining 24 h after ethanol treatments.</p>
            <p>(B) Quantification of Fluoro-Jade–B positive cells in the cingulate cortex
              (ANOVA <italic>F<sub>2,13</sub>
              </italic> = 25.541; <italic>p &lt;</italic> 0.0001; <italic>n</italic> =
              5–6 each treatment group), in the total CA1 region of hippocampus (ANOVA
                  <italic>F<sub>2,13</sub>
              </italic> = 9.988; <italic>p</italic> = 0.0024; <italic>n</italic> = 5–6
              each treatment group), and in the LDN of thalamus (ANOVA <italic>F<sub>2,13</sub>
              </italic> = 20.785; <italic>p</italic> &lt; 0.0001; <italic>n</italic> =
              5–6 each treatment group). </p>
            <p>(C) Total number of NeuN positive cells were counted 2 wk after ethanol
              administration in the cingulate cortex (ANOVA <italic>F<sub>2,12</sub>
              </italic> = 9.894; <italic>p</italic> = 0.0029; <italic>n</italic> = 5 each treatment
              group), in the CA1 region of hippocampus (ANOVA <italic>F<sub>2,12</sub>
              </italic> = 7.289; <italic>p</italic> = 0.0085; <italic>n</italic> = 5 each treatment
              group) and in the LDN of thalamus (ANOVA <italic>F<sub>2,12</sub>
              </italic> = 5.551; <italic>p</italic> = 0.0196; <italic>n</italic> = 5 each treatment
              group). Values are shown as mean ± SD. Bonferroni correction for multiple
              comparison revealed a significant difference between ethanol treatment group and all
              other groups. </p>
            <p>S, saline; E, ethanol; Etoh+Nic, ethanol + nicotinamide. Scale bars 200μm.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.0030101.g003" xlink:type="simple"/>
        </fig>
      </sec>
      <sec id="s3d">
        <title>Nicotinamide Prevents Ethanol-Induced Behavioral Impairment in Adult Mice</title>
        <p>Rodents exposed to ethanol during early development show several behavioral and cognitive
          impairments as adults, and these impairments appear to correlate with ethanol-induced
          neuronal loss [<xref ref-type="bibr" rid="pmed-0030101-b033">33</xref>, <xref ref-type="bibr" rid="pmed-0030101-b040">40</xref>–<xref ref-type="bibr" rid="pmed-0030101-b042">42</xref>]. We have shown here that nicotinamide
          inhibits the decrease in the number of neurons following ethanol exposure during early
          postnatal development. To examine if this effect on neuronal death could prevent
          behavioral deficits, we conducted a series of behavioral tests on adult mice that had been
          exposed to ethanol during early development. Animals were exposed to either saline,
          ethanol, ethanol/nicotinamide, or saline/nicotinamide at P7. Mice were tested starting at
          2 mo of age, and all behavioral tests were conducted blind to the treatment. First, we
          assessed spontaneous locomotor activity by placing the mice in the open field box for 5
          min. Ethanol-treated mice showed increases in the number of lines crossed (horizontal
          activity) but not in the number of rears (vertical activity) (<xref ref-type="table" rid="pmed-0030101-t001">Table 1</xref> and unpublished data). Administration of 1 mg/g
          nicotinamide alone did not influence the spontaneous activity of the mice, compared with
          saline-treated mice (<xref ref-type="table" rid="pmed-0030101-t001">Table 1</xref>).
          However when nicotinamide was administrated after ethanol in P7 mice, it completely
          prevented the increase of activity exhibited in adult ethanol-treated mice (<xref ref-type="table" rid="pmed-0030101-t001">Table 1</xref>). </p>
        <table-wrap id="pmed-0030101-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pmed.0030101.t001</object-id><label>Table 1</label><caption>
            <title>Nicotinamide Reverts Ethanol-Induced Hyperactivity in Adult Mice</title>
          </caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.0030101.t001" xlink:type="simple"/><!-- <table><thead><TR><TD align="left" valign="bottom" ROWSPAN="1" COLSPAN="1"><HR>Test</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"><HR>Treatment</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"><HR><ITALIC>n</ITALIC></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"><HR>Mean</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"><HR>SD</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"><HR>95&percnt; CI Low</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"><HR>95&percnt; CI High</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"><HR><ITALIC>p</ITALIC>-Value<sup>a</sup> Saline</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"><HR><ITALIC>p</ITALIC>-Value<sup>a</sup> EtOH</TD></TR></thead><tbody><TR><TD valign="bottom" ROWSPAN="1" COLSPAN="1">Open Field</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD></TR><TR><TD COLSPAN="2" ROWSPAN="1">Total lines crossed</TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD></TR><TR><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1">Saline</TD><TD ROWSPAN="1" COLSPAN="1">33</TD><TD ROWSPAN="1" COLSPAN="1">128.097</TD><TD ROWSPAN="1" COLSPAN="1">32.312</TD><TD ROWSPAN="1" COLSPAN="1">117.073</TD><TD ROWSPAN="1" COLSPAN="1">139.121</TD><TD ROWSPAN="1" COLSPAN="1">0</TD><TD ROWSPAN="1" COLSPAN="1"><BOLD>0.0012</BOLD></TD></TR><TR><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1">EtOH</TD><TD ROWSPAN="1" COLSPAN="1">34</TD><TD ROWSPAN="1" COLSPAN="1">158.471</TD><TD ROWSPAN="1" COLSPAN="1">42.157</TD><TD ROWSPAN="1" COLSPAN="1">144.301</TD><TD ROWSPAN="1" COLSPAN="1">172.641</TD><TD ROWSPAN="1" COLSPAN="1"><BOLD>0.0012</BOLD></TD><TD ROWSPAN="1" COLSPAN="1">0</TD></TR><TR><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1">EtOH + Nic</TD><TD ROWSPAN="1" COLSPAN="1">33</TD><TD ROWSPAN="1" COLSPAN="1">125.242</TD><TD ROWSPAN="1" COLSPAN="1">30.927</TD><TD ROWSPAN="1" COLSPAN="1">114.690</TD><TD ROWSPAN="1" COLSPAN="1">135.794</TD><TD ROWSPAN="1" COLSPAN="1">0.7569</TD><TD ROWSPAN="1" COLSPAN="1"><BOLD>0.0003</BOLD></TD></TR><TR><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">Saline + Nic</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">31</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">132.030</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">40.039</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">117.935</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">146.125</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">0.6698</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"><BOLD>0.0039</BOLD></TD></TR><TR><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD></TR><TR><TD valign="bottom" ROWSPAN="1" COLSPAN="1">Plus Maze</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD></TR><TR><TD COLSPAN="2" ROWSPAN="1">Total entries</TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD></TR><TR><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1">Saline</TD><TD ROWSPAN="1" COLSPAN="1">33</TD><TD ROWSPAN="1" COLSPAN="1">16.469</TD><TD ROWSPAN="1" COLSPAN="1">4.813</TD><TD ROWSPAN="1" COLSPAN="1">14.827</TD><TD ROWSPAN="1" COLSPAN="1">18.111</TD><TD ROWSPAN="1" COLSPAN="1">0</TD><TD ROWSPAN="1" COLSPAN="1"><BOLD>0.0030</BOLD></TD></TR><TR><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1">EtOH</TD><TD ROWSPAN="1" COLSPAN="1">34</TD><TD ROWSPAN="1" COLSPAN="1">20.118</TD><TD ROWSPAN="1" COLSPAN="1">5.698</TD><TD ROWSPAN="1" COLSPAN="1">18.203</TD><TD ROWSPAN="1" COLSPAN="1">22.033</TD><TD ROWSPAN="1" COLSPAN="1"><BOLD>0.0030</BOLD></TD><TD ROWSPAN="1" COLSPAN="1">0</TD></TR><TR><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1">EtOH + Nic</TD><TD ROWSPAN="1" COLSPAN="1">33</TD><TD ROWSPAN="1" COLSPAN="1">16.515</TD><TD ROWSPAN="1" COLSPAN="1">5.026</TD><TD ROWSPAN="1" COLSPAN="1">14.800</TD><TD ROWSPAN="1" COLSPAN="1">18.230</TD><TD ROWSPAN="1" COLSPAN="1">0.9695</TD><TD ROWSPAN="1" COLSPAN="1"><BOLD>0.0031</BOLD></TD></TR><TR><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">Saline + Nic</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">31</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">15.030</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">3.795</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">13.694</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">16.366</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">0.2378</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">&lt;<BOLD>0.0001</BOLD></TD></TR><TR><TD COLSPAN="4" ROWSPAN="1">&percnt; Entries in open arms</TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD></TR><TR><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1">Saline</TD><TD ROWSPAN="1" COLSPAN="1">33</TD><TD ROWSPAN="1" COLSPAN="1">8.841</TD><TD ROWSPAN="1" COLSPAN="1">8.956</TD><TD ROWSPAN="1" COLSPAN="1">5.785</TD><TD ROWSPAN="1" COLSPAN="1">11.897</TD><TD ROWSPAN="1" COLSPAN="1">0</TD><TD ROWSPAN="1" COLSPAN="1"><BOLD>0.001</BOLD></TD></TR><TR><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1">EtOH</TD><TD ROWSPAN="1" COLSPAN="1">34</TD><TD ROWSPAN="1" COLSPAN="1">18.950</TD><TD ROWSPAN="1" COLSPAN="1">14.366</TD><TD ROWSPAN="1" COLSPAN="1">14.121</TD><TD ROWSPAN="1" COLSPAN="1">23.779</TD><TD ROWSPAN="1" COLSPAN="1"><BOLD>0.001</BOLD></TD><TD ROWSPAN="1" COLSPAN="1">0</TD></TR><TR><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1">EtOH + Nic</TD><TD ROWSPAN="1" COLSPAN="1">33</TD><TD ROWSPAN="1" COLSPAN="1">10.388</TD><TD ROWSPAN="1" COLSPAN="1">11.881</TD><TD ROWSPAN="1" COLSPAN="1">6.334</TD><TD ROWSPAN="1" COLSPAN="1">14.442</TD><TD ROWSPAN="1" COLSPAN="1">0.6087</TD><TD ROWSPAN="1" COLSPAN="1"><BOLD>0.0046</BOLD></TD></TR><TR><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">Saline + Nic</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">31</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">9.299</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">12.598</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">4.864</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">13.734</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">0.8794</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"><BOLD>0.0015</BOLD></TD></TR><TR><TD COLSPAN="3" ROWSPAN="1">&percnt; Time in open arms</TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD></TR><TR><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1">Saline</TD><TD ROWSPAN="1" COLSPAN="1">33</TD><TD ROWSPAN="1" COLSPAN="1">3.866</TD><TD ROWSPAN="1" COLSPAN="1">5.549</TD><TD ROWSPAN="1" COLSPAN="1">1.973</TD><TD ROWSPAN="1" COLSPAN="1">5.759</TD><TD ROWSPAN="1" COLSPAN="1">0</TD><TD ROWSPAN="1" COLSPAN="1"><BOLD>0.0007</BOLD></TD></TR><TR><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1">EtOH</TD><TD ROWSPAN="1" COLSPAN="1">34</TD><TD ROWSPAN="1" COLSPAN="1">10.176</TD><TD ROWSPAN="1" COLSPAN="1">9.765</TD><TD ROWSPAN="1" COLSPAN="1">6.894</TD><TD ROWSPAN="1" COLSPAN="1">13.458</TD><TD ROWSPAN="1" COLSPAN="1"><BOLD>0.0007</BOLD></TD><TD ROWSPAN="1" COLSPAN="1">0</TD></TR><TR><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1">EtOH + Nic</TD><TD ROWSPAN="1" COLSPAN="1">33</TD><TD ROWSPAN="1" COLSPAN="1">4.919</TD><TD ROWSPAN="1" COLSPAN="1">6.645</TD><TD ROWSPAN="1" COLSPAN="1">2.652</TD><TD ROWSPAN="1" COLSPAN="1">7.186</TD><TD ROWSPAN="1" COLSPAN="1">0.564</TD><TD ROWSPAN="1" COLSPAN="1"><BOLD>0.0040</BOLD></TD></TR><TR><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">Saline + Nic</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">31</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">4.374</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">6.544</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">2.070</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">6.678</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">0.7809</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"><BOLD>0.0015</BOLD></TD></TR></tbody></table> --><!-- <table-wrap-foot>
						<fn id="nt101">
							<p>
								<p>
									<sup>a</sup>
									<italic>p</italic>-Value from ANOVA followed by Bonferroni correction. Comparisons are considered significant with a 
									<italic>p</italic>-value less than 0.083.
								</p>
							</p>
						</fn>
						<fn id="nt102">
							<p>
								<p>Boldfaced numbers indicate 
									<italic>p</italic>-values that are significant.
								</p>
							</p>
						</fn>
					</table-wrap-foot> --></table-wrap>
        <p>The mice were then tested in the elevated plus maze. This task relies on the conflict
          between a mouse's natural aversion to open space and its exploratory behavior. Entries
          into the open arms are indicative of reduced anxiety or fear, while the total entries into
          all the arms correlate with activity level [<xref ref-type="bibr" rid="pmed-0030101-b035">35</xref>]. Ethanol-treated mice showed an increase in
          the total number of entries into both open and closed arms, indicating increased activity
            (<xref ref-type="table" rid="pmed-0030101-t001">Table 1</xref>). Furthermore,
          ethanol-treated mice made more entries into the open arms and also stayed there for longer
          periods of time (<xref ref-type="table" rid="pmed-0030101-t001">Table 1</xref>). In
          contrast, ethanol-treated mice that received nicotinamide did not show any differences
          when compared with saline-treated mice (<xref ref-type="table" rid="pmed-0030101-t001">Table 1</xref>). </p>
        <p>Finally, to test hippocampal learning and memory we used a fear-conditioning paradigm. In
          this test, mice learn to associate a context (experimental chamber) or cue (tone) with a
          foot shock. Contextual fear conditioning is hippocampus-dependent, while cued fear
          conditioning is hippocampus-independent. Prior to presentation of the first shock/tone
          pairing, all the mice showed a low level of freezing, and ANOVA analysis did not show any
          difference between the different groups (F<sub>3,65</sub> = 2.271; <italic>p</italic> =
          0.0885; <italic>n</italic> = 16–18 each treatment group) (<xref ref-type="table" rid="pmed-0030101-t002">Table 2</xref>). 24 h after training, ethanol-treated mice
          showed significant impairment in contextual fear conditioning, displaying a significantly
          decreased level of freezing. Nicotinamide administration completely prevented the
          performance impairment induced by ethanol (<xref ref-type="table" rid="pmed-0030101-t002">Table 2</xref>). Furthermore, 48 h after training, the same mice were tested with the
          conditioned stimulus (tone) in a novel chamber. All groups displayed similar and
          statistically indistinguishable freezing responses in both the new context before
          (pre-tone: ANOVA <italic>F<sub>3,122</sub>
          </italic> = 1.074; <italic>p</italic> = 0.3626; <italic>n</italic> = 31–33 each
          treatment group) and during the presentation of tone cue (tone: ANOVA
              <italic>F<sub>3,128</sub>
          </italic> = 1.312; <italic>p</italic> = 0.2733; <italic>n</italic> = 31–34 each
          treatment group) (<xref ref-type="table" rid="pmed-0030101-t002">Table 2</xref>). These
          results suggest that exposure to ethanol, in the postnatal period, affects
          hippocampal-dependent memory in adult mice. </p>
        <table-wrap id="pmed-0030101-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pmed.0030101.t002</object-id><label>Table 2</label><caption>
            <title>Nicotinamide Prevents Ethanol-Induced Impairment Performance in the Contextual
              Fear-Conditioning Test</title>
          </caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.0030101.t002" xlink:type="simple"/><!-- <table><thead><TR><TD align="left" valign="bottom" ROWSPAN="1" COLSPAN="1"><HR>Test</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"><HR>Treatment</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"><HR><ITALIC>n</ITALIC></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"><HR>Mean<sup>a</sup></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"><HR>SD</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"><HR>95&percnt; CI Low</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"><HR>95&percnt; CI High</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"><HR><ITALIC>p</ITALIC>-Value<sup>b</sup> Saline</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"><HR><ITALIC>p</ITALIC>-Value<sup>b</sup> EtOH</TD></TR></thead><tbody><TR><TD COLSPAN="2" ROWSPAN="1">Pre-training</TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD></TR><TR><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1">Saline</TD><TD ROWSPAN="1" COLSPAN="1">18</TD><TD ROWSPAN="1" COLSPAN="1">3.002</TD><TD ROWSPAN="1" COLSPAN="1">3.252</TD><TD ROWSPAN="1" COLSPAN="1">1.500</TD><TD ROWSPAN="1" COLSPAN="1">4.754</TD><TD ROWSPAN="1" COLSPAN="1">ns</TD><TD ROWSPAN="1" COLSPAN="1">Ns</TD></TR><TR><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1">EtOH</TD><TD ROWSPAN="1" COLSPAN="1">18</TD><TD ROWSPAN="1" COLSPAN="1">0.763</TD><TD ROWSPAN="1" COLSPAN="1">2.447</TD><TD ROWSPAN="1" COLSPAN="1">&minus;0.367</TD><TD ROWSPAN="1" COLSPAN="1">3.577</TD><TD ROWSPAN="1" COLSPAN="1">ns</TD><TD ROWSPAN="1" COLSPAN="1">Ns</TD></TR><TR><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1">EtOH + Nic</TD><TD ROWSPAN="1" COLSPAN="1">16</TD><TD ROWSPAN="1" COLSPAN="1">1.926</TD><TD ROWSPAN="1" COLSPAN="1">3.427</TD><TD ROWSPAN="1" COLSPAN="1">0.247</TD><TD ROWSPAN="1" COLSPAN="1">5.106</TD><TD ROWSPAN="1" COLSPAN="1">ns</TD><TD ROWSPAN="1" COLSPAN="1">Ns</TD></TR><TR><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">Saline + Nic</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">17</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">1.201</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">1.413</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">0.529</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">2.085</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">ns</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">Ns</TD></TR><TR><TD COLSPAN="2" ROWSPAN="1">Context</TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD></TR><TR><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1">Saline</TD><TD ROWSPAN="1" COLSPAN="1">33</TD><TD ROWSPAN="1" COLSPAN="1">33.656</TD><TD ROWSPAN="1" COLSPAN="1">14.561</TD><TD ROWSPAN="1" COLSPAN="1">28.688</TD><TD ROWSPAN="1" COLSPAN="1">19.529</TD><TD ROWSPAN="1" COLSPAN="1">0</TD><TD ROWSPAN="1" COLSPAN="1"><BOLD>0.0002</BOLD></TD></TR><TR><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1">EtOH</TD><TD ROWSPAN="1" COLSPAN="1">34</TD><TD ROWSPAN="1" COLSPAN="1">21.540</TD><TD ROWSPAN="1" COLSPAN="1">11.320</TD><TD ROWSPAN="1" COLSPAN="1">17.735</TD><TD ROWSPAN="1" COLSPAN="1">15.125</TD><TD ROWSPAN="1" COLSPAN="1"><BOLD>0.0002</BOLD></TD><TD ROWSPAN="1" COLSPAN="1">0</TD></TR><TR><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1">EtOH + Nic</TD><TD ROWSPAN="1" COLSPAN="1">33</TD><TD ROWSPAN="1" COLSPAN="1">29.933</TD><TD ROWSPAN="1" COLSPAN="1">11.813</TD><TD ROWSPAN="1" COLSPAN="1">25.903</TD><TD ROWSPAN="1" COLSPAN="1">15.843</TD><TD ROWSPAN="1" COLSPAN="1">0.2399</TD><TD ROWSPAN="1" COLSPAN="1"><BOLD>0.0078</BOLD></TD></TR><TR><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">Saline + Nic</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">31</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">33.752</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">13.003</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">29.175</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">17.580</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">0.9759</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1"><BOLD>0.0001</BOLD></TD></TR><TR><TD COLSPAN="2" ROWSPAN="1">Pre-tone</TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD></TR><TR><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1">Saline</TD><TD ROWSPAN="1" COLSPAN="1">33</TD><TD ROWSPAN="1" COLSPAN="1">16.819</TD><TD ROWSPAN="1" COLSPAN="1">10.698</TD><TD ROWSPAN="1" COLSPAN="1">13.169</TD><TD ROWSPAN="1" COLSPAN="1">14.348</TD><TD ROWSPAN="1" COLSPAN="1">ns</TD><TD ROWSPAN="1" COLSPAN="1">ns</TD></TR><TR><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1">EtOH</TD><TD ROWSPAN="1" COLSPAN="1">31</TD><TD ROWSPAN="1" COLSPAN="1">14.547</TD><TD ROWSPAN="1" COLSPAN="1">8.678</TD><TD ROWSPAN="1" COLSPAN="1">11.492</TD><TD ROWSPAN="1" COLSPAN="1">11.733</TD><TD ROWSPAN="1" COLSPAN="1">ns</TD><TD ROWSPAN="1" COLSPAN="1">ns</TD></TR><TR><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1">EtOH + Nic</TD><TD ROWSPAN="1" COLSPAN="1">31</TD><TD ROWSPAN="1" COLSPAN="1">13.798</TD><TD ROWSPAN="1" COLSPAN="1">8.164</TD><TD ROWSPAN="1" COLSPAN="1">10.924</TD><TD ROWSPAN="1" COLSPAN="1">11.038</TD><TD ROWSPAN="1" COLSPAN="1">ns</TD><TD ROWSPAN="1" COLSPAN="1">ns</TD></TR><TR><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">Saline + Nic</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">31</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">17.104</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">7.617</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">14.423</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">10.298</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">ns</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">ns</TD></TR><TR><TD COLSPAN="2" ROWSPAN="1">Tone</TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1"></TD></TR><TR><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1">Saline</TD><TD ROWSPAN="1" COLSPAN="1">33</TD><TD ROWSPAN="1" COLSPAN="1">53.190</TD><TD ROWSPAN="1" COLSPAN="1">14.165</TD><TD ROWSPAN="1" COLSPAN="1">48.357</TD><TD ROWSPAN="1" COLSPAN="1">18.998</TD><TD ROWSPAN="1" COLSPAN="1">ns</TD><TD ROWSPAN="1" COLSPAN="1">ns</TD></TR><TR><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1">EtOH</TD><TD ROWSPAN="1" COLSPAN="1">34</TD><TD ROWSPAN="1" COLSPAN="1">51.459</TD><TD ROWSPAN="1" COLSPAN="1">18.381</TD><TD ROWSPAN="1" COLSPAN="1">45.281</TD><TD ROWSPAN="1" COLSPAN="1">24.559</TD><TD ROWSPAN="1" COLSPAN="1">ns</TD><TD ROWSPAN="1" COLSPAN="1">ns</TD></TR><TR><TD ROWSPAN="1" COLSPAN="1"></TD><TD ROWSPAN="1" COLSPAN="1">EtOH + Nic</TD><TD ROWSPAN="1" COLSPAN="1">33</TD><TD ROWSPAN="1" COLSPAN="1">55.864</TD><TD ROWSPAN="1" COLSPAN="1">17.513</TD><TD ROWSPAN="1" COLSPAN="1">49.889</TD><TD ROWSPAN="1" COLSPAN="1">23.488</TD><TD ROWSPAN="1" COLSPAN="1">ns</TD><TD ROWSPAN="1" COLSPAN="1">ns</TD></TR><TR><TD valign="bottom" ROWSPAN="1" COLSPAN="1"></TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">Saline + Nic</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">31</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">60.496</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">16.901</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">54.547</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">22.850</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">ns</TD><TD valign="bottom" ROWSPAN="1" COLSPAN="1">ns</TD></TR></tbody></table> --><!-- <table-wrap-foot>
						<fn id="nt201">
							<p>
								<p>
									<sup>a</sup>&percnt; of time spent freezing.
								</p>
							</p>
						</fn>
						<fn id="nt202">
							<p>
								<p>
									<sup>b</sup>
									<italic>p</italic>-Value from ANOVA followed by Bonferroni correction. Comparisons are considered significant with a 
									<italic>p</italic>-value less than 0.083.
								</p>
							</p>
						</fn>
						<fn id="nt203">
							<p>
								<p>Boldfaced numbers indicate 
									<italic>p</italic>-values that are significant.
								</p>
							</p>
						</fn>
						<fn id="nt204">
							<p>
								<p>ns, not significant.</p></p>
						</fn>
					</table-wrap-foot> --></table-wrap>
      </sec>
    </sec>
    <sec id="s4">
      <title>Discussion</title>
      <p>In this study, we have demonstrated that the administration of nicotinamide after ethanol
        treatment in early postnatal development prevents alcohol-induced hyperactivity and memory
        impairment in adult mice. The memory impairment in contextual fear conditioning and
        behavioral hyperactivity both correlated with an increase in neuronal death in cingulate
        cortex and hippocampus. Administration of nicotinamide protected against this
        ethanol-induced apoptosis, suggesting a link between neuronal loss during brain development
        and behavioral disturbances observed in the adult mice. Interestingly, we established that
        administration of ethanol in postnatal mice induced extensive neuronal death predominantly
        in the ventral region of the hippocampus. This is consistent with recently published
        findings that damage to the ventral part of hippocampus significantly impairs performance in
        contextual fear conditioning [<xref ref-type="bibr" rid="pmed-0030101-b043">43</xref>]. Our findings of an increase in the number of entries into the open
        arm and in the time of permanence in the open arm in ethanol-treated mice are consistent
        with data previously published [<xref ref-type="bibr" rid="pmed-0030101-b033">33</xref>, <xref ref-type="bibr" rid="pmed-0030101-b044">44</xref>]. However, to
        better understand whether this behavioral phenotype is due to an anxiolytic effect or simply
        to an increase of activity, additional studies are needed. </p>
      <p>Neuroprotection by nicotinamide in ethanol toxicity appears to function at the
        mitochondrial level. In the present study, we show that nicotinamide in vivo prevents
        ethanol-induced cytochrome-c release and the following caspase-3 activation. Our data are
        consistent with previous studies showing that nicotinamide inhibits oxygen-glucose
        deprivation-induced neuronal death in vitro, by preventing release of cytochrome-c
          [<xref ref-type="bibr" rid="pmed-0030101-b023">23</xref>]. Although the
        determination of the precise mechanisms underlying the effects of nicotinamide require
        furthers analysis, it is possible that nicotinamide may function in stabilizing the cellular
        energy metabolism [<xref ref-type="bibr" rid="pmed-0030101-b016">16</xref>]. During an oxidative stress, depletion of NAD+ is considered a critical
        factor in precipitating cell death due to compromised energy supply [<xref ref-type="bibr" rid="pmed-0030101-b045">45</xref>]. Administration of
        nicotinamide increases the amount of NAD+ in the brain, preventing its depletion and
        consequent energetic decline [<xref ref-type="bibr" rid="pmed-0030101-b017">17</xref>, <xref ref-type="bibr" rid="pmed-0030101-b046">46</xref>]. This is
        consistent with a recent study in which increasing NAD+ biosynthesis prevented axonal
        degeneration [<xref ref-type="bibr" rid="pmed-0030101-b047">47</xref>]. </p>
      <p>Although there are other studies showing a possible protective effect of antioxidants in
        preventing ethanol-induced apoptotic neuronal death, to our knowledge this is the first
        treatment that has been shown to work at the molecular, cellular, and behavioral levels. It
        has been shown that treatment with the synthetic antioxidant ebselen decreases
        ethanol-induced apoptotic cell death of young neurons in the adult dentate gyrus
          [<xref ref-type="bibr" rid="pmed-0030101-b048">48</xref>].
        Administration of an active fragment of the glial-derived activity-dependent neuroprotective
        protein, which has potent anti-oxidative properties, prevents ethanol-induced growth
        retardation in mouse whole-embryo culture and neurotoxicity in vitro [<xref ref-type="bibr" rid="pmed-0030101-b049">49</xref>]. Other studies have
        demonstrated that vitamin E and β-carotene protect against ethanol-induced neuronal
        death in vitro [<xref ref-type="bibr" rid="pmed-0030101-b050">50</xref>, <xref ref-type="bibr" rid="pmed-0030101-b051">51</xref>]. However, the protective
        effects of vitamin E in vivo are controversial. While Heaton et al. [<xref ref-type="bibr" rid="pmed-0030101-b052">52</xref>] have shown that vitamin E
        protects against ethanol-induced loss of Purkinje cells of the cerebellum, Tran et al.
          [<xref ref-type="bibr" rid="pmed-0030101-b053">53</xref>] have found
        that vitamin E does not prevent ethanol-induced caspase-3 activation, cerebellar damage, or
        behavioral impairment. Furthermore, it has been shown that while a pretreatment with a large
        dose of vitamin E prevents ethanol-induced cell loss and oxidative stress in the neonatal
        rat hippocampus, this treatment did not prevent behavioral impairment in ethanol-exposed
        mice [<xref ref-type="bibr" rid="pmed-0030101-b054">54</xref>]. </p>
      <p>Although nicotinamide was previously used in another model of FAS [<xref ref-type="bibr" rid="pmed-0030101-b055">55</xref>], the present study has
        demonstrated for the first time that nicotinamide exerts a protective effect against
        ethanol-induced apoptotic cell death and adult neurobehavioral disturbances. We tested
        nicotinamide between 0 h and 8 h after administration of ethanol, and while we saw the
        highest level of protection between 0 h and 2 h, nicotinamide treatment retained some effect
        even after a delay of 8 h (<xref ref-type="fig" rid="pmed-0030101-g001">Figure 1</xref>E and
          <xref ref-type="fig" rid="pmed-0030101-g001">1</xref>G; <xref ref-type="supplementary-material" rid="st004">Table S4</xref>). We used a dose of ethanol
        that achieved extremely high blood levels that were maintained for more than 12 h, and yet
        we were able to reverse the neurobiological effects of ethanol. An important aspect of our
        study is that nicotinamide has been used for several years in some clinical trials to treat
        type-I diabetes and bullous pemphigoid (a chronic, autoimmune, blistering disease), orally
        and in large daily doses for up to five years with little or no side effects [<xref ref-type="bibr" rid="pmed-0030101-b056">56</xref>–<xref ref-type="bibr" rid="pmed-0030101-b059">59</xref>]. Furthermore, there is no evidence that
        nicotinamide is teratogenic by itself [<xref ref-type="bibr" rid="pmed-0030101-b060">60</xref>]. In conclusion, although additional studies
        are necessary, we suggest, based on the data presented here, that nicotinamide, a readily
        available and safe agent, could eventually be used in the treatment and prevention of the
        devastating sequellae of FAS. </p>
    </sec>
    <sec id="s5">
      <title>Supporting Information</title>
      <supplementary-material id="sd001" mimetype="application/pdf" position="anchor" xlink:href="info:doi/10.1371/journal.pmed.0030101.sd001" xlink:type="simple">
        <label>Alternative Language Abstract S1</label>
        <caption>
          <title>Italian Translation of the Abstract</title>
          <p>(29 KB PDF).</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="sd002" mimetype="application/pdf" position="anchor" xlink:href="info:doi/10.1371/journal.pmed.0030101.sd002" xlink:type="simple">
        <label>Alternative Language Abstract S2</label>
        <caption>
          <title>Spanish Translation of the Abstract</title>
          <p>(35 KB PDF).</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="sg001" mimetype="application/pdf" position="anchor" xlink:href="info:doi/10.1371/journal.pmed.0030101.sg001" xlink:type="simple">
        <label>Figure S1</label>
        <caption>
          <title>Ethanol Induces Activation of Caspase-3</title>
          <p>(A) Ethanol was injected into P7 mice, and activation of caspase-3 was detected at a
            different time point by Western blot. (B and C) 1-methylnicotinamide does not prevent
            ethanol-induced activation of caspase-3. P7 mice were injected with ethanol and
            nicotinamide or 1-methylnicotinamide, an analogue of nicotinamide, administered 2 h
            after ethanol exposure. At the dose of 1 mg/g, 1-methyl-nicotinamide was toxic. Western
            blot analysis of activated caspase-3 12 h after ethanol exposure (B) and correspondent
            densitometric quantification (ANOVA <italic>F<sub>4,18</sub>
            </italic> = 10.705 <italic>p</italic> = 0.0014; <italic>n</italic> = 4–5 each
            treatment group) (C). </p>
          <p>Values are shown as mean ± SD. Multiple comparison by Bonferroni's procedure
            revealed a significant difference between the ethanol treatment group and all other
            groups. No statistical differences were present between ethanol and ethanol plus
            1-methyl-nicotinamide.</p>
          <p>(1.1 MB PDF).</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="st001" mimetype="application/msword" position="anchor" xlink:href="info:doi/10.1371/journal.pmed.0030101.st001" xlink:type="simple">
        <label>Table S1</label>
        <caption>
          <title>Experimental Groups</title>
          <p>(53 KB DOC).</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="st002" mimetype="application/msword" position="anchor" xlink:href="info:doi/10.1371/journal.pmed.0030101.st002" xlink:type="simple">
        <label>Table S2</label>
        <caption>
          <title>Nicotinamide Inhibits Ethanol-Induced Caspase-3 Activation</title>
          <p>Western blot densitometric analysis of caspase-3 activation 12 h after ethanol
            treatment and different doses of nicotinamide administration.</p>
          <p>(31 KB DOC).</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="st003" mimetype="application/msword" position="anchor" xlink:href="info:doi/10.1371/journal.pmed.0030101.st003" xlink:type="simple">
        <label>Table S3</label>
        <caption>
          <title>Nicotinamide Inhibits Ethanol-Induced Caspase-3 Activation</title>
          <p>Western blot densitometric analysis of caspase-3 activation 24 h after ethanol
            treatment.</p>
          <p>(28 KB DOC).</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="st004" mimetype="application/msword" position="anchor" xlink:href="info:doi/10.1371/journal.pmed.0030101.st004" xlink:type="simple">
        <label>Table S4</label>
        <caption>
          <title>Nicotinamide Inhibits Ethanol-Induced Caspase-3 Activation</title>
          <p>Western blot densitometric analysis of caspase-3 activation 12 h after ethanol
            treatment and different time points of nicotinamide administration.</p>
          <p>(31 KB DOC).</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="st005" mimetype="application/msword" position="anchor" xlink:href="info:doi/10.1371/journal.pmed.0030101.st005" xlink:type="simple">
        <label>Table S5</label>
        <caption>
          <title>Nicotinamide Inhibits Ethanol-Induced Caspase-3 Activation</title>
          <p>Western blot densitometric analysis of caspase-3 activation 12 h after different doses
            of ethanol administration.</p>
          <p>(31 KB DOC).</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="st006" mimetype="application/msword" position="anchor" xlink:href="info:doi/10.1371/journal.pmed.0030101.st006" xlink:type="simple">
        <label>Table S6</label>
        <caption>
          <title>Nicotinamide Inhibits Ethanol-Induced Caspase-3 Activation</title>
          <p>Western blot densitometric analysis of caspase-3 activation 12 h after ethanol
            treatment using nicotinamide or an analogue of nicotinamide.</p>
          <p>(29 KB DOC).</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="st007" mimetype="application/msword" position="anchor" xlink:href="info:doi/10.1371/journal.pmed.0030101.st007" xlink:type="simple">
        <label>Table S7</label>
        <caption>
          <title>Nicotinamide Blocks Release of Citochrome-c from Mitochondria</title>
          <p>Western blot densitometric analysis of cytochrome-c release from mitochondria 12 h
            after ethanol administration.</p>
          <p>(28 KB DOC).</p>
        </caption>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>We are grateful to Drs. S. Anderson, F. Lee, N. Schiff, G. DeErausquin, B. Seri, Oliver
        Tuscher and L. Perrone for useful comments after reading this manuscript. We are grateful to
        Lucia Collado for her help to carry on the behavioral tests. We are thankful to Andrew Leon
        for statistical advice.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="pmed-0030101-b001">
        <label>1</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Jones</surname>
              <given-names>KL</given-names>
            </name>
            <name name-style="western">
              <surname>Smith</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
          <article-title>Recognition of the fetal alcohol syndrome in early infancy.</article-title>
          <source>Lancet</source>
          <year>1973</year>
          <volume>2</volume>
          <fpage>999</fpage>
          <lpage>1001</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b002">
        <label>2</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Sokol</surname>
              <given-names>RJ</given-names>
            </name>
            <name name-style="western">
              <surname>Delaney-Black</surname>
              <given-names>V</given-names>
            </name>
            <name name-style="western">
              <surname>Nordstrom</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Fetal alcohol spectrum disorder.</article-title>
          <source>JAMA</source>
          <year>2003</year>
          <volume>290</volume>
          <fpage>2996</fpage>
          <lpage>2999</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b003">
        <label>3</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Eckardt</surname>
              <given-names>MJ</given-names>
            </name>
            <name name-style="western">
              <surname>File</surname>
              <given-names>SE</given-names>
            </name>
            <name name-style="western">
              <surname>Gessa</surname>
              <given-names>GL</given-names>
            </name>
            <name name-style="western">
              <surname>Grant</surname>
              <given-names>KA</given-names>
            </name>
            <name name-style="western">
              <surname>Guerri</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effects of moderate alcohol consumption on the central nervous
            system.</article-title>
          <source>Alcohol Clin Exp Res</source>
          <year>1998</year>
          <volume>22</volume>
          <fpage>998</fpage>
          <lpage>1040</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b004">
        <label>4</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Goodlett</surname>
              <given-names>CR</given-names>
            </name>
            <name name-style="western">
              <surname>Horn</surname>
              <given-names>KH</given-names>
            </name>
            <name name-style="western">
              <surname>Zhou</surname>
              <given-names>FC</given-names>
            </name>
          </person-group>
          <article-title>Alcohol teratogenesis: Mechanisms of damage and strategies for
            intervention.</article-title>
          <source>Exp Biol Med (Maywood)</source>
          <year>2005</year>
          <volume>230</volume>
          <fpage>394</fpage>
          <lpage>406</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b005">
        <label>5</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Bonthius</surname>
              <given-names>DJ</given-names>
            </name>
            <name name-style="western">
              <surname>West</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Alcohol-induced neuronal loss in developing rats: Increased brain damage
            with binge exposure.</article-title>
          <source>Alcohol Clin Exp Res</source>
          <year>1990</year>
          <volume>14</volume>
          <fpage>107</fpage>
          <lpage>118</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b006">
        <label>6</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Miller</surname>
              <given-names>MW</given-names>
            </name>
          </person-group>
          <article-title>Effects of alcohol on the generation and migration of cerebral cortical
            neurons.</article-title>
          <source>Science</source>
          <year>1986</year>
          <volume>233</volume>
          <fpage>1308</fpage>
          <lpage>1311</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b007">
        <label>7</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Miller</surname>
              <given-names>MW</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms of ethanol induced neuronal death during development: from the
            molecule to behavior.</article-title>
          <source>Alcohol Clin Exp Res</source>
          <year>1996</year>
          <volume>20</volume>
          <fpage>128A</fpage>
          <lpage>132A</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b008">
        <label>8</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Ikonomidou</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Bittigau</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Ishimaru</surname>
              <given-names>MJ</given-names>
            </name>
            <name name-style="western">
              <surname>Wozniak</surname>
              <given-names>DF</given-names>
            </name>
            <name name-style="western">
              <surname>Koch</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ethanol-induced apoptotic neurodegeneration and fetal alcohol
            syndrome.</article-title>
          <source>Science</source>
          <year>2000</year>
          <volume>287</volume>
          <fpage>1056</fpage>
          <lpage>1060</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b009">
        <label>9</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Olney</surname>
              <given-names>JW</given-names>
            </name>
            <name name-style="western">
              <surname>Ishimaru</surname>
              <given-names>MJ</given-names>
            </name>
            <name name-style="western">
              <surname>Bittigau</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Ikonomidou</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Ethanol-induced apoptotic neurodegeneration in the developing
            brain.</article-title>
          <source>Apoptosis</source>
          <year>2000</year>
          <volume>5</volume>
          <fpage>515</fpage>
          <lpage>521</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b010">
        <label>10</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Holmes</surname>
              <given-names>GL</given-names>
            </name>
          </person-group>
          <article-title>Morphological and physiological maturation of the brain in the neonate and
            young child.</article-title>
          <source>J Clin Neurophysiol</source>
          <year>1986</year>
          <volume>3</volume>
          <fpage>209</fpage>
          <lpage>238</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b011">
        <label>11</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Burd</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Klug</surname>
              <given-names>MG</given-names>
            </name>
            <name name-style="western">
              <surname>Martsolf</surname>
              <given-names>JT</given-names>
            </name>
            <name name-style="western">
              <surname>Kerbeshian</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Fetal alcohol syndrome: Neuropsychiatric phenomics.</article-title>
          <source>Neurotoxicol Teratol</source>
          <year>2003</year>
          <volume>25</volume>
          <fpage>697</fpage>
          <lpage>705</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b012">
        <label>12</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Olney</surname>
              <given-names>JW</given-names>
            </name>
            <name name-style="western">
              <surname>Tenkova</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Dikranian</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Qin</surname>
              <given-names>YQ</given-names>
            </name>
            <name name-style="western">
              <surname>Labruyere</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ethanol-induced apoptotic neurodegeneration in the developing C57BL/6 mouse
            brain.</article-title>
          <source>Brain Res Dev Brain Res</source>
          <year>2002</year>
          <volume>133</volume>
          <fpage>115</fpage>
          <lpage>126</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b013">
        <label>13</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Olney</surname>
              <given-names>JW</given-names>
            </name>
            <name name-style="western">
              <surname>Wozniak</surname>
              <given-names>DF</given-names>
            </name>
            <name name-style="western">
              <surname>Jevtovic-Todorovic</surname>
              <given-names>V</given-names>
            </name>
            <name name-style="western">
              <surname>Ikonomidou</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Glutamate signaling and the fetal alcohol syndrome.</article-title>
          <source>Ment Retard Dev Disabil Res Rev</source>
          <year>2001</year>
          <volume>7</volume>
          <fpage>267</fpage>
          <lpage>275</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b014">
        <label>14</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Carloni</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Mazzoni</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Balduini</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Caspase-3 and calpain activities after acute and repeated ethanol
            administration during the rat brain growth spurt.</article-title>
          <source>J Neurochem</source>
          <year>2004</year>
          <volume>89</volume>
          <fpage>197</fpage>
          <lpage>203</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b015">
        <label>15</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Olney</surname>
              <given-names>JW</given-names>
            </name>
            <name name-style="western">
              <surname>Tenkova</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Dikranian</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Muglia</surname>
              <given-names>LJ</given-names>
            </name>
            <name name-style="western">
              <surname>Jermakowicz</surname>
              <given-names>WJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ethanol-induced caspase-3 activation in the in vivo developing mouse
            brain.</article-title>
          <source>Neurobiol Dis</source>
          <year>2002</year>
          <volume>9</volume>
          <fpage>205</fpage>
          <lpage>219</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b016">
        <label>16</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Maiese</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Chong</surname>
              <given-names>ZZ</given-names>
            </name>
          </person-group>
          <article-title>Nicotinamide: Necessary nutrient emerges as a novel cytoprotectant for the
            brain.</article-title>
          <source>Trends Pharmacol Sci</source>
          <year>2003</year>
          <volume>24</volume>
          <fpage>228</fpage>
          <lpage>232</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b017">
        <label>17</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Mukherjee</surname>
              <given-names>SK</given-names>
            </name>
            <name name-style="western">
              <surname>Klaidman</surname>
              <given-names>LK</given-names>
            </name>
            <name name-style="western">
              <surname>Yasharel</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Adams</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>Increased brain NAD prevents neuronal apoptosis in vivo.</article-title>
          <source>Eur J Pharmacol</source>
          <year>1997</year>
          <volume>330</volume>
          <fpage>27</fpage>
          <lpage>34</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b018">
        <label>18</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Klaidman</surname>
              <given-names>LK</given-names>
            </name>
            <name name-style="western">
              <surname>Mukherjee</surname>
              <given-names>SK</given-names>
            </name>
            <name name-style="western">
              <surname>Adams</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>Oxidative changes in brain pyridine nucleotides and neuroprotection using
            nicotinamide.</article-title>
          <source>Biochim Biophys Acta</source>
          <year>2001</year>
          <volume>1525</volume>
          <fpage>136</fpage>
          <lpage>148</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b019">
        <label>19</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Yang</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Klaidman</surname>
              <given-names>LK</given-names>
            </name>
            <name name-style="western">
              <surname>Chang</surname>
              <given-names>ML</given-names>
            </name>
            <name name-style="western">
              <surname>Kem</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Sugawara</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nicotinamide therapy protects against both necrosis and apoptosis in a
            stroke model.</article-title>
          <source>Pharmacol Biochem Behav</source>
          <year>2002</year>
          <volume>73</volume>
          <fpage>901</fpage>
          <lpage>910</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b020">
        <label>20</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Lin</surname>
              <given-names>SH</given-names>
            </name>
            <name name-style="western">
              <surname>Chong</surname>
              <given-names>ZZ</given-names>
            </name>
            <name name-style="western">
              <surname>Maiese</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Nicotinamide: A nutritional supplement that provides protection against
            neuronal and vascular injury.</article-title>
          <source>J Med Food</source>
          <year>2001</year>
          <volume>4</volume>
          <fpage>27</fpage>
          <lpage>38</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b021">
        <label>21</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Ayoub</surname>
              <given-names>IA</given-names>
            </name>
            <name name-style="western">
              <surname>Lee</surname>
              <given-names>EJ</given-names>
            </name>
            <name name-style="western">
              <surname>Ogilvy</surname>
              <given-names>CS</given-names>
            </name>
            <name name-style="western">
              <surname>Beal</surname>
              <given-names>MF</given-names>
            </name>
            <name name-style="western">
              <surname>Maynard</surname>
              <given-names>KI</given-names>
            </name>
          </person-group>
          <article-title>Nicotinamide reduces infarction up to two hours after the onset of
            permanent focal cerebral ischemia in Wistar rats.</article-title>
          <source>Neurosci Lett</source>
          <year>1999</year>
          <volume>259</volume>
          <fpage>21</fpage>
          <lpage>24</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b022">
        <label>22</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Chong</surname>
              <given-names>ZZ</given-names>
            </name>
            <name name-style="western">
              <surname>Lin</surname>
              <given-names>SH</given-names>
            </name>
            <name name-style="western">
              <surname>Maiese</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Nicotinamide modulates mitochondrial membrane potential and cysteine
            protease activity during cerebral vascular endothelial cell injury.</article-title>
          <source>J Vasc Res</source>
          <year>2002</year>
          <volume>39</volume>
          <fpage>131</fpage>
          <lpage>147</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b023">
        <label>23</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Chong</surname>
              <given-names>ZZ</given-names>
            </name>
            <name name-style="western">
              <surname>Lin</surname>
              <given-names>SH</given-names>
            </name>
            <name name-style="western">
              <surname>Maiese</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>The NAD+ precursor nicotinamide governs neuronal survival during oxidative
            stress through protein kinase B coupled to FOXO3a and mitochondrial membrane
            potential.</article-title>
          <source>J Cereb Blood Flow Metab</source>
          <year>2004</year>
          <volume>24</volume>
          <fpage>728</fpage>
          <lpage>743</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b024">
        <label>24</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Bossy-Wetzel</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Green</surname>
              <given-names>DR</given-names>
            </name>
          </person-group>
          <article-title>Assays for cytochrome c release from mitochondria during
            apoptosis.</article-title>
          <source>Methods Enzymol</source>
          <year>2000</year>
          <volume>322</volume>
          <fpage>235</fpage>
          <lpage>242</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b025">
        <label>25</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Schmued</surname>
              <given-names>LC</given-names>
            </name>
            <name name-style="western">
              <surname>Hopkins</surname>
              <given-names>KJ</given-names>
            </name>
          </person-group>
          <article-title>Fluoro-Jade B: A high affinity fluorescent marker for the localization of
            neuronal degeneration.</article-title>
          <source>Brain Res</source>
          <year>2000</year>
          <volume>874</volume>
          <fpage>123</fpage>
          <lpage>130</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b026">
        <label>26</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Gittins</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Harrison</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Neuronal density, size and shape in the human anterior cingulate cortex: A
            comparison of Nissl and NeuN staining.</article-title>
          <source>Brain Res Bull</source>
          <year>2004</year>
          <volume>63</volume>
          <fpage>155</fpage>
          <lpage>160</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b027">
        <label>27</label>
        <nlm-citation publication-type="book" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Paxinos</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Franklin</surname>
              <given-names>KBJ</given-names>
            </name>
          </person-group>
          <source>The mouse brain in stereotaxic coordinates</source>
          <year>1997</year>
          <publisher-loc>San Diego</publisher-loc>
          <publisher-name>Academic Press</publisher-name>
          <page-count count="186"/>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b028">
        <label>28</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Gundersen</surname>
              <given-names>HJ</given-names>
            </name>
          </person-group>
          <article-title>Stereology of arbitrary particles. A review of unbiased number and size
            estimators and the presentation of some new ones, in memory of William R.
            Thompson.</article-title>
          <source>J Microsc</source>
          <year>1986</year>
          <volume>143</volume>
          <issue>Pt 1</issue>
          <fpage>3</fpage>
          <lpage>45</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b029">
        <label>29</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>West</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Stereological methods for estimating the total number of neurons and
            synapses: Issues of precision and bias.</article-title>
          <source>Trends Neurosci</source>
          <year>1999</year>
          <volume>22</volume>
          <fpage>51</fpage>
          <lpage>61</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b030">
        <label>30</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>West</surname>
              <given-names>MJ</given-names>
            </name>
            <name name-style="western">
              <surname>Gundersen</surname>
              <given-names>HJ</given-names>
            </name>
          </person-group>
          <article-title>Unbiased stereological estimation of the number of neurons in the human
            hippocampus.</article-title>
          <source>J Comp Neurol</source>
          <year>1990</year>
          <volume>296</volume>
          <fpage>1</fpage>
          <lpage>22</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b031">
        <label>31</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Allan</surname>
              <given-names>AM</given-names>
            </name>
            <name name-style="western">
              <surname>Chynoweth</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Tyler</surname>
              <given-names>LA</given-names>
            </name>
            <name name-style="western">
              <surname>Caldwell</surname>
              <given-names>KK</given-names>
            </name>
          </person-group>
          <article-title>A mouse model of prenatal ethanol exposure using a voluntary drinking
            paradigm.</article-title>
          <source>Alcohol Clin Exp Res</source>
          <year>2003</year>
          <volume>27</volume>
          <fpage>2009</fpage>
          <lpage>2016</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b032">
        <label>32</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Melcer</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Gonzalez</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Riley</surname>
              <given-names>EP</given-names>
            </name>
          </person-group>
          <article-title>Locomotor activity and alcohol preference in alcohol-preferring and
            -nonpreferring rats following neonatal alcohol exposure.</article-title>
          <source>Neurotoxicol Teratol</source>
          <year>1995</year>
          <volume>17</volume>
          <fpage>41</fpage>
          <lpage>48</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b033">
        <label>33</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Osborn</surname>
              <given-names>JA</given-names>
            </name>
            <name name-style="western">
              <surname>Kim</surname>
              <given-names>CK</given-names>
            </name>
            <name name-style="western">
              <surname>Steiger</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Weinberg</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Prenatal ethanol exposure differentially alters behavior in males and
            females on the elevated plus maze.</article-title>
          <source>Alcohol Clin Exp Res</source>
          <year>1998</year>
          <volume>22</volume>
          <fpage>685</fpage>
          <lpage>696</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b034">
        <label>34</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Shah</surname>
              <given-names>KR</given-names>
            </name>
            <name name-style="western">
              <surname>West</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Behavioral changes in rat following perinatal exposure to
            ethanol.</article-title>
          <source>Neurosci Lett</source>
          <year>1984</year>
          <volume>47</volume>
          <fpage>145</fpage>
          <lpage>148</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b035">
        <label>35</label>
        <nlm-citation publication-type="book" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Crawley</surname>
              <given-names>JN</given-names>
            </name>
          </person-group>
          <source>What's wrong with my mouse?: Behavioral phenotyping of transgenic and knockout
            mice</source>
          <year>2000</year>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>John Wiley &amp; Sons</publisher-name>
          <page-count count="368"/>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b036">
        <label>36</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Powell</surname>
              <given-names>CM</given-names>
            </name>
            <name name-style="western">
              <surname>Schoch</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Monteggia</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Barrot</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Matos</surname>
              <given-names>MF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The presynaptic active zone protein RIM1alpha is critical for normal
            learning and memory.</article-title>
          <source>Neuron</source>
          <year>2004</year>
          <volume>42</volume>
          <fpage>143</fpage>
          <lpage>153</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b037">
        <label>37</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Zeng</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Chattarji</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Barbarosie</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Rondi-Reig</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Philpot</surname>
              <given-names>BD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Forebrain-specific calcineurin knockout selectively impairs bidirectional
            synaptic plasticity and working/episodic-like memory.</article-title>
          <source>Cell</source>
          <year>2001</year>
          <volume>107</volume>
          <fpage>617</fpage>
          <lpage>629</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b038">
        <label>38</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Ikonomidou</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Bittigau</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Koch</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Genz</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Hoerster</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Neurotransmitters and apoptosis in the developing brain.</article-title>
          <source>Biochem Pharmacol</source>
          <year>2001</year>
          <volume>62</volume>
          <fpage>401</fpage>
          <lpage>405</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b039">
        <label>39</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Young</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Klocke</surname>
              <given-names>BJ</given-names>
            </name>
            <name name-style="western">
              <surname>Tenkova</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Choi</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Labruyere</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ethanol-induced neuronal apoptosis in vivo requires BAX in the developing
            mouse brain.</article-title>
          <source>Cell Death Differ</source>
          <year>2003</year>
          <volume>10</volume>
          <fpage>1148</fpage>
          <lpage>1155</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b040">
        <label>40</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Wozniak</surname>
              <given-names>DF</given-names>
            </name>
            <name name-style="western">
              <surname>Hartman</surname>
              <given-names>RE</given-names>
            </name>
            <name name-style="western">
              <surname>Boyle</surname>
              <given-names>MP</given-names>
            </name>
            <name name-style="western">
              <surname>Vogt</surname>
              <given-names>SK</given-names>
            </name>
            <name name-style="western">
              <surname>Brooks</surname>
              <given-names>AR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Apoptotic neurodegeneration induced by ethanol in neonatal mice is
            associated with profound learning/memory deficits in juveniles followed by progressive
            functional recovery in adults.</article-title>
          <source>Neurobiol Dis</source>
          <year>2004</year>
          <volume>17</volume>
          <fpage>403</fpage>
          <lpage>414</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b041">
        <label>41</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Iqbal</surname>
              <given-names>U</given-names>
            </name>
            <name name-style="western">
              <surname>Dringenberg</surname>
              <given-names>HC</given-names>
            </name>
            <name name-style="western">
              <surname>Brien</surname>
              <given-names>JF</given-names>
            </name>
            <name name-style="western">
              <surname>Reynolds</surname>
              <given-names>JN</given-names>
            </name>
          </person-group>
          <article-title>Chronic prenatal ethanol exposure alters hippocampal GABA(A) receptors and
            impairs spatial learning in the guinea pig.</article-title>
          <source>Behav Brain Res</source>
          <year>2004</year>
          <volume>150</volume>
          <fpage>117</fpage>
          <lpage>125</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b042">
        <label>42</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Nagahara</surname>
              <given-names>AH</given-names>
            </name>
            <name name-style="western">
              <surname>Handa</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Loss of nicotine-induced effects on locomotor activity in fetal
            alcohol-exposed rats.</article-title>
          <source>Neurotoxicol Teratol</source>
          <year>1999</year>
          <volume>21</volume>
          <fpage>647</fpage>
          <lpage>652</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b043">
        <label>43</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Rudy</surname>
              <given-names>JW</given-names>
            </name>
            <name name-style="western">
              <surname>Matus-Amat</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>The ventral hippocampus supports a memory representation of context and
            contextual fear conditioning: Implications for a unitary function of the
            hippocampus.</article-title>
          <source>Behav Neurosci</source>
          <year>2005</year>
          <volume>119</volume>
          <fpage>154</fpage>
          <lpage>163</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b044">
        <label>44</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Carneiro</surname>
              <given-names>LM</given-names>
            </name>
            <name name-style="western">
              <surname>Diogenes</surname>
              <given-names>JP</given-names>
            </name>
            <name name-style="western">
              <surname>Vasconcelos</surname>
              <given-names>SM</given-names>
            </name>
            <name name-style="western">
              <surname>Aragao</surname>
              <given-names>GF</given-names>
            </name>
            <name name-style="western">
              <surname>Noronha</surname>
              <given-names>EC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Behavioral and neurochemical effects on rat offspring after prenatal
            exposure to ethanol.</article-title>
          <source>Neurotoxicol Teratol</source>
          <year>2005</year>
          <volume>27</volume>
          <fpage>585</fpage>
          <lpage>592</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b045">
        <label>45</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Beal</surname>
              <given-names>MF</given-names>
            </name>
          </person-group>
          <article-title>Energetics in the pathogenesis of neurodegenerative
            diseases.</article-title>
          <source>Trends Neurosci</source>
          <year>2000</year>
          <volume>23</volume>
          <fpage>298</fpage>
          <lpage>304</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b046">
        <label>46</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Yang</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Klaidman</surname>
              <given-names>LK</given-names>
            </name>
            <name name-style="western">
              <surname>Nalbandian</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Oliver</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Chang</surname>
              <given-names>ML</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The effects of nicotinamide on energy metabolism following transient focal
            cerebral ischemia in Wistar rats.</article-title>
          <source>Neurosci Lett</source>
          <year>2002</year>
          <volume>333</volume>
          <fpage>91</fpage>
          <lpage>94</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b047">
        <label>47</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Araki</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Sasaki</surname>
              <given-names>Y</given-names>
            </name>
            <name name-style="western">
              <surname>Milbrandt</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal
            degeneration.</article-title>
          <source>Science</source>
          <year>2004</year>
          <volume>305</volume>
          <fpage>1010</fpage>
          <lpage>1013</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b048">
        <label>48</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Herrera</surname>
              <given-names>DG</given-names>
            </name>
            <name name-style="western">
              <surname>Yague</surname>
              <given-names>AG</given-names>
            </name>
            <name name-style="western">
              <surname>Johnsen-Soriano</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Bosch-Morell</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>Collado-Morente</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Selective impairment of hippocampal neurogenesis by chronic alcoholism:
            Protective effects of an antioxidant.</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2003</year>
          <volume>100</volume>
          <fpage>7919</fpage>
          <lpage>7924</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b049">
        <label>49</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Wilkemeyer</surname>
              <given-names>MF</given-names>
            </name>
            <name name-style="western">
              <surname>Chen</surname>
              <given-names>SY</given-names>
            </name>
            <name name-style="western">
              <surname>Menkari</surname>
              <given-names>CE</given-names>
            </name>
            <name name-style="western">
              <surname>Brenneman</surname>
              <given-names>DE</given-names>
            </name>
            <name name-style="western">
              <surname>Sulik</surname>
              <given-names>KK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Differential effects of ethanol antagonism and neuroprotection in peptide
            fragment NAPVSIPQ prevention of ethanol-induced developmental toxicity.</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2003</year>
          <volume>100</volume>
          <fpage>8543</fpage>
          <lpage>8548</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b050">
        <label>50</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Heaton</surname>
              <given-names>MB</given-names>
            </name>
            <name name-style="western">
              <surname>Madorsky</surname>
              <given-names>I</given-names>
            </name>
            <name name-style="western">
              <surname>Paiva</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Siler-Marsiglio</surname>
              <given-names>KI</given-names>
            </name>
          </person-group>
          <article-title>Vitamin E amelioration of ethanol neurotoxicity involves modulation of
            apoptotis-related protein levels in neonatal rat cerebellar granule
            cells.</article-title>
          <source>Brain Res Dev Brain Res</source>
          <year>2004</year>
          <volume>150</volume>
          <fpage>117</fpage>
          <lpage>124</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b051">
        <label>51</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Mitchell</surname>
              <given-names>JJ</given-names>
            </name>
            <name name-style="western">
              <surname>Paiva</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Heaton</surname>
              <given-names>MB</given-names>
            </name>
          </person-group>
          <article-title>The antioxidants vitamin E and beta-carotene protect against
            ethanol-induced neurotoxicity in embryonic rat hippocampal cultures.</article-title>
          <source>Alcohol</source>
          <year>1999</year>
          <volume>17</volume>
          <fpage>163</fpage>
          <lpage>168</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b052">
        <label>52</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Heaton</surname>
              <given-names>MB</given-names>
            </name>
            <name name-style="western">
              <surname>Mitchell</surname>
              <given-names>JJ</given-names>
            </name>
            <name name-style="western">
              <surname>Paiva</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Amelioration of ethanol-induced neurotoxicity in the neonatal rat central
            nervous system by antioxidant therapy.</article-title>
          <source>Alcohol Clin Exp Res</source>
          <year>2000</year>
          <volume>24</volume>
          <fpage>512</fpage>
          <lpage>518</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b053">
        <label>53</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Tran</surname>
              <given-names>TD</given-names>
            </name>
            <name name-style="western">
              <surname>Jackson</surname>
              <given-names>HD</given-names>
            </name>
            <name name-style="western">
              <surname>Horn</surname>
              <given-names>KH</given-names>
            </name>
            <name name-style="western">
              <surname>Goodlett</surname>
              <given-names>CR</given-names>
            </name>
          </person-group>
          <article-title>Vitamin E does not protect against neonatal ethanol-induced cerebellar
            damage or deficits in eyeblink classical conditioning in rats.</article-title>
          <source>Alcohol Clin Exp Res</source>
          <year>2005</year>
          <volume>29</volume>
          <fpage>117</fpage>
          <lpage>129</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b054">
        <label>54</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Marino</surname>
              <given-names>MD</given-names>
            </name>
            <name name-style="western">
              <surname>Aksenov</surname>
              <given-names>MY</given-names>
            </name>
            <name name-style="western">
              <surname>Kelly</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <article-title>Vitamin E protects against alcohol-induced cell loss and oxidative stress
            in the neonatal rat hippocampus.</article-title>
          <source>Int J Dev Neurosci</source>
          <year>2004</year>
          <volume>22</volume>
          <fpage>363</fpage>
          <lpage>377</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b055">
        <label>55</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Tanaka</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Nakazawa</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Suzuki</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Arima</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Prevention possibility for brain dysfunction in rat with the fetal alcohol
            syndrome–low-zinc-status and hypoglycemia.</article-title>
          <source>Brain Dev</source>
          <year>1982</year>
          <volume>4</volume>
          <fpage>429</fpage>
          <lpage>438</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b056">
        <label>56</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Crino</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Schiaffini</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Manfrini</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Mesturino</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Visalli</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A randomized trial of nicotinamide and vitamin E in children with recent
            onset type 1 diabetes (IMDIAB IX).</article-title>
          <source>Eur J Endocrinol</source>
          <year>2004</year>
          <volume>150</volume>
          <issue>5</issue>
          <fpage>719</fpage>
          <lpage>724</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b057">
        <label>57</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Loo</surname>
              <given-names>WJ</given-names>
            </name>
            <name name-style="western">
              <surname>Dean</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Wojnarowska</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>A severe persistent case of recurrent pemphigoid gestationis successfully
            treated with minocycline and nicotinamide.</article-title>
          <source>Clin Exp Dermatol</source>
          <year>2001</year>
          <volume>26</volume>
          <issue>8</issue>
          <fpage>726</fpage>
          <lpage>727</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b058">
        <label>58</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Olmos</surname>
              <given-names>PR</given-names>
            </name>
            <name name-style="western">
              <surname>Hodgson</surname>
              <given-names>MI</given-names>
            </name>
            <name name-style="western">
              <surname>Maiz</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Manrique</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>De Valdes</surname>
              <given-names>MD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nicotinamide protected first-phase insulin response (FPIR) and prevented
            clinical disease in first-degree relatives of type-1 diabetics.</article-title>
          <source>Diabetes Res Clin Pract: In Press</source>
          <year>2005</year>
          <comment>doi: <ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1016/jdiabres.2005.07.009" xlink:type="simple">10.1016/jdiabres.2005.07.009</ext-link></comment>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b059">
        <label>59</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Walsh</surname>
              <given-names>SR</given-names>
            </name>
            <name name-style="western">
              <surname>Hogg</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Mydlarski</surname>
              <given-names>PR</given-names>
            </name>
          </person-group>
          <article-title>Bullous pemphigoid: From bench to bedside.</article-title>
          <source>Drugs</source>
          <year>2005</year>
          <volume>65</volume>
          <fpage>905</fpage>
          <lpage>926</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030101-b060">
        <label>60</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Knip</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Douek</surname>
              <given-names>IF</given-names>
            </name>
            <name name-style="western">
              <surname>Moore</surname>
              <given-names>WP</given-names>
            </name>
            <name name-style="western">
              <surname>Gillmor</surname>
              <given-names>HA</given-names>
            </name>
            <name name-style="western">
              <surname>McLean</surname>
              <given-names>AE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Safety of high-dose nicotinamide: A review.</article-title>
          <source>Diabetologia</source>
          <year>2000</year>
          <volume>43</volume>
          <fpage>1337</fpage>
          <lpage>1345</lpage>
        </nlm-citation>
      </ref>
    </ref-list>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>ADN</term>
          <def>
            <p>antero dorsal nucleus</p>
          </def>
        </def-item>
        <def-item>
          <term>AVN</term>
          <def>
            <p>antero ventral nucleus</p>
          </def>
        </def-item>
        <def-item>
          <term>CX</term>
          <def>
            <p>cortex</p>
          </def>
        </def-item>
        <def-item>
          <term>DG</term>
          <def>
            <p>dental gyrus</p>
          </def>
        </def-item>
        <def-item>
          <term>EtOH</term>
          <def>
            <p>ethanol</p>
          </def>
        </def-item>
        <def-item>
          <term>FAE</term>
          <def>
            <p>fetal alcohol effect</p>
          </def>
        </def-item>
        <def-item>
          <term>FAS</term>
          <def>
            <p>fetal alcohol syndrome</p>
          </def>
        </def-item>
        <def-item>
          <term>LDN</term>
          <def>
            <p>lateral dorsal nucleus</p>
          </def>
        </def-item>
        <def-item>
          <term>NAD+</term>
          <def>
            <p>β-nicotinamide adenine ninucleotide</p>
          </def>
        </def-item>
        <def-item>
          <term>NeuN</term>
          <def>
            <p>neuronal nuclear protein</p>
          </def>
        </def-item>
        <def-item>
          <term>Nic</term>
          <def>
            <p>nicotinamide</p>
          </def>
        </def-item>
        <def-item>
          <term>P[number]</term>
          <def>
            <p>postnatal day [number]</p>
          </def>
        </def-item>
        <def-item>
          <term>SD</term>
          <def>
            <p>standard deviation</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    
  </back>
</article>